0001193125-23-300560.txt : 20231221 0001193125-23-300560.hdr.sgml : 20231221 20231221092058 ACCESSION NUMBER: 0001193125-23-300560 CONFORMED SUBMISSION TYPE: N-CSR PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20231031 FILED AS OF DATE: 20231221 DATE AS OF CHANGE: 20231221 EFFECTIVENESS DATE: 20231221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: T. Rowe Price Global Funds, Inc. CENTRAL INDEX KEY: 0000852254 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CSR SEC ACT: 1940 Act SEC FILE NUMBER: 811-05833 FILM NUMBER: 231503021 BUSINESS ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 410-345-2000 MAIL ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 FORMER COMPANY: FORMER CONFORMED NAME: T. Rowe Price Institutional International Funds, Inc. DATE OF NAME CHANGE: 20051028 FORMER COMPANY: FORMER CONFORMED NAME: T ROWE PRICE INSTITUTIONAL INTERNATIONAL FUNDS INC DATE OF NAME CHANGE: 20011217 FORMER COMPANY: FORMER CONFORMED NAME: INSTITUTIONAL INTERNATIONAL FUNDS INC DATE OF NAME CHANGE: 19920703 0000852254 S000029530 T. Rowe Price Institutional International Disciplined Equity Fund C000090615 T. Rowe Price Institutional International Disciplined Equity Fund RPICX N-CSR 1 d610564dncsr.htm INSTITUTIONAL INTERNATIONAL DISCIPLINED EQUITY FUND_ICE_E177-050 Institutional International Disciplined Equity Fund_ICE_E177-050

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act File Number: 811-05833

T. Rowe Price Global Funds, Inc.

 

(Exact name of registrant as specified in charter)

100 East Pratt Street, Baltimore, MD 21202

 

(Address of principal executive offices)

David Oestreicher

100 East Pratt Street, Baltimore, MD 21202

 

(Name and address of agent for service)

Registrant’s telephone number, including area code: (410) 345-2000

Date of fiscal year end: October 31

Date of reporting period: October 31, 2023


Item 1. Reports to Shareholders

(a) Report pursuant to Rule 30e-1


Annual
REPORT
October
31,
2023
Institutional
International
Disciplined
Equity
Fund
T.
ROWE
PRICE
For
more
insights
from
T.
Rowe
Price
investment
professionals,
go
to
troweprice.com
.
Highlights
and
Market
Commentary
Management’s
Discussion
of
Fund
Performance
Performance
and
Expenses
Financial
Highlights
Portfolio
of
Investments
Financial
Statements
and
Notes
Additional
Fund
Information
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
HIGHLIGHTS
International
stocks
rose
in
the
12
months
ended
October
31,
2023,
as
signs
of
easing
inflation
in
many
markets
raised
hopes
that
global
central
banks
were
nearing
an
end
to
their
tightening
cycles,
though
concerns
about
higher-for-longer
rates
and
China’s
growth
slowdown
spurred
declines
in
the
final
months
of
the
period.
The
Institutional
International
Disciplined
Equity
Fund
recorded
a
double-digit
gain
over
its
fiscal
year
and
outperformed
the
MSCI
EAFE
Index
Net.
Health
care
and
consumer
staples
were
the
largest
overweight
sectors
at
fiscal
year-end,
while
industrials
and
business
services
was
the
most
underweight
sector.
Financial
markets
were
quick
to
price
in
a
negative
outlook
toward
our
fiscal
year-end,
but
we
believe
that
markets
may
prove
to
be
surprisingly
resilient
in
the
near
term,
barring
a
deep
recession.
Log
in
to
your
account
at
troweprice.com
for
more
information.
*
An
account
service
fee
will
be
charged
annually
for
each
T.
Rowe
Price
mutual
fund
account
unless
you
meet
criteria
for
a
fee
waiver.
Go
to
troweprice.
com/personal-investing/help/fees-and-minimums.html
to
learn
more
about
this
account
service
fee,
including
other
ways
to
waive
it.
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
Market
Commentary
1
Dear
Investor
Most
major
global
stock
and
bond
indexes
produced
positive
results
during
your
fund’s
fiscal
year,
the
12-month
period
ended
October
31,
2023,
although
a
downturn
over
the
past
six
months
offset
some
of
the
strong
gains
recorded
in
the
first
half
of
the
period.
Global
economies
managed
to
avoid
the
recession
that
was
widely
predicted
at
the
start
of
2023,
but
signs
that
central
banks
might
need
to
keep
interest
rates
higher
for
longer
than
previously
expected
weighed
on
market
sentiment.
Growth
stocks
outperformed
value
shares
over
the
12-month
period,
and
stocks
in
developed
markets
generally
outpaced
their
counterparts
in
emerging
markets.
Currency
movements
were
mixed
over
the
period,
although
a
weaker
dollar
versus
major
European
currencies
was
beneficial
for
U.S.
investors
in
European
securities.
Technology
companies
benefited
from
investor
enthusiasm
for
artificial
intelligence
developments
and
produced
some
of
the
strongest
results
in
the
equity
market.
Within
the
S&P
500
Index,
the
communication
services
and
information
technology
sectors
were
lifted
by
the
rally
in
tech-related
companies
and
recorded
significant
gains.
The
financials
sector
partly
recovered
from
the
failure
of
three
large
regional
banks
during
the
period
but
still
finished
in
negative
territory.
Corporate
fundamentals
were
broadly
supportive.
Although
year-over-year
earnings
growth
contracted
in
the
first
and
second
quarters
of
2023,
results
were
better
than
expected,
and
preliminary
estimates
pointed
to
a
resumption
of
growth
in
the
third
quarter.
The
U.S.
economy
was
the
strongest
among
the
major
markets
during
the
period,
with
gross
domestic
product
growth
coming
in
at
4.9%
in
the
third
quarter’s
initial
estimate,
the
highest
since
the
end
of
2021.
Growth
in
Europe
and
Japan
was
more
sluggish,
and
China’s
economy
was
beset
by
worries
about
its
property
sector
after
an
initial
boost
from
its
decision
at
the
end
of
2022
to
lift
most
of
its
pandemic-related
restrictions.
A
protracted
debt
ceiling
standoff
in
the
U.S.,
the
ongoing
conflict
between
Ukraine
and
Russia,
and
the
outbreak
of
war
in
the
Middle
East
following
the
attack
on
Israel
by
Hamas
produced
headwinds
for
markets
at
various
times.
Investors
also
remained
focused
on
inflation
as
price
increases
moderated
but
remained
well
above
the
Federal
Reserve’s
2%
target.
In
response,
the
Fed
continued
to
raise
its
short-term
lending
benchmark
rate,
lifting
it
to
a
target
range
of
5.25%
to
5.50%
by
the
end
of
July,
the
highest
level
since
March
2001.
U.S.
Treasury
yields
increased
as
the
Fed
tightened
monetary
policy
and
investors
priced
in
the
possibility
that
the
central
bank
may
have
to
keep
rates
higher
for
longer
than
previously
anticipated.
In
addition,
Treasuries
were
pressured
by
Fitch
Ratings’
decision
to
downgrade
the
credit
rating
of
U.S.
government
debt
from
the
highest
level,
AAA,
to
AA+
along
with
expectations
for
higher
levels
of
borrowing
by
the
Treasury
Department.
The
yield
on
the
benchmark
10-year
Treasury
note
briefly
reached
5.00%
in
October
for
the
first
time
since
late
2007
before
falling
back
to
4.88%
by
period-end.
Increasing
yields
over
the
past
six
months
led
to
weak
results
across
most
of
the
fixed
income
market,
although
high
yield
bonds,
which
are
less
sensitive
to
rising
rates,
held
up
relatively
well
as
default
rates
remained
low
by
historical
standards.
Global
economies
and
markets
showed
surprising
resilience
in
2023,
but
considerable
uncertainty
remains
as
we
look
ahead
to
2024.
Geopolitical
events,
the
path
of
monetary
policy,
and
the
impact
of
the
Fed’s
rate
hikes
on
the
economy
all
raise
the
potential
for
additional
volatility.
We
believe
this
environment
makes
skilled
active
management
a
critical
tool
for
identifying
risks
and
opportunities,
and
our
investment
teams
will
continue
to
use
fundamental
research
to
identify
securities
that
have
the
potential
to add
value
to
your
portfolio
over
the
long
term.
Thank
you
for
your
continued
confidence
in
T.
Rowe
Price.
Sincerely,
Robert
Sharps
CEO
and
President
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
Management’s
Discussion
of
Fund
Performance
2
INVESTMENT
OBJECTIVE 
The
fund
seeks
long-term
growth
of
capital
through
investments
in
stocks
of
non-U.S.
companies.
FUND
COMMENTARY
How
did
the
fund
perform
in
the
past 12
months?
The
Institutional
International
Disciplined
Equity
Fund
returned
14.74%
in
the
12
months
ended
October
31,
2023.
The
fund
outperformed
the
MSCI
EAFE
Index
Net,
which
returned
14.40%,
and
the
Lipper
International
Multi-Cap
Core
Funds
Average,
which
returned
13.72%.
(Returns
for
the
Advisor
and
I
Class
shares
will
vary
due
to
their
different
fee
structures.
Past
performance
cannot
guarantee
future
results
.)
What
factors
influenced
the
fund’s
performance?
Industrials
and
business
services
stocks
added
the
most
to
relative
returns
thanks
to
positive
selection,
led
by
our
position
in
Rolls-Royce.
Shares
of
the
UK
aerospace
and
defense
company
roughly
doubled
over
our
fiscal
year
as
its
business
rebounded
from
the
coronavirus
pandemic
and
its
financial
performance
improved
under
a
new
chief
executive
who
implemented
an
extensive
turnaround
of
the
company
shortly
after
taking
over
in
January.
Mitsubishi,
Japan’s
largest
trading
company,
was
another
key
contributor
in
industrials
after
it
announced
record
net
profit
for
the
fiscal
year
ended
in
March
and
a
substantial
share
buyback
plan.
Communication
services
companies
helped
relative
performance
owing
to
favorable
stock
selection
and
an
underweight
to
the
sector,
which
lagged
the
benchmark.
Millicom
International,
a
Latin
American
telecommunications
operator,
was
a
large
contributor
to
relative
returns
amid
reports
of
takeover
interest
from
several
private
investors.
(Please
refer
to
the
portfolio
of
investments
for
a
complete
list
of
holdings
and
the
amount
each
represents
in
the
portfolio.)
Turning
to
detractors,
financial
stocks
detracted
the
most
from
relative
performance
due
to
negative
stock
selection,
led
by
positions
in
European
investment
companies
Groupe
Bruxelles
Lambert
(GBL),
HAL
Trust,
and
Wendel,
all
of
which
lagged
the
financials
sector’s
stronger
return.
GBL
and
HAL
Trust
detracted
after
each
reported
disappointing
earnings
in
their
underlying
portfolio
companies,
while
Wendel
underperformed
as
investors
retreated
from
smaller-cap
companies
over
the
period.
Consumer
staples
weighed
on
relative
performance
owing
to
adverse
stock
selection
and
an
overweight
to
the
sector,
which
underperformed
the
benchmark.
Barry
Callebaut,
a
Switzerland-based
chocolate
and
cocoa
products
manufacturer,
hurt
relative
returns
after
the
company
reported
a
drop
in
sales
volume
for
the
first
nine
months
of
the
year
as
food
inflation
curbed
discretionary
spending.
How
is
the
fund
positioned?
The
Institutional
International
Disciplined
Equity
Fund
seeks
to
own
mispriced,
quality
companies
outside
the
U.S.
that
offer
a
compelling
combination
of
business
fundamentals,
earnings
growth
potential,
and
relative
valuation.
Country
positioning
is
driven
by
bottom-up
stock
selection
based
on
the
fundamental
research
performed
by
T.
Rowe
Price’s
equity
analyst
team
but
is
also
influenced
by
top-down
views.
Health
care
and
consumer
staples,
both
defensive
areas
that
we
believe
will
maintain
reasonable
topline
growth
and
pricing
power,
were
the
largest
overweight
sectors
at
fiscal
year-end.
Conversely,
industrials
and
business
services
followed
by
consumer
discretionary
were
the
most
underweight
sectors.
Financials
was
the
fund’s
largest
sector
in
absolute
terms
and
a
modest
overweight
versus
the
benchmark
at
period-end.
Our
holdings
are
concentrated
in
the
financial
services
industry
through
positions
in
European
financial
conglomerates,
including
Brussels-based
Groupe
Bruxelles
Lambert,
Dutch
investment
company
HAL
Trust,
and
Sweden’s
L
E
Lundbergforetagen
(Lundbergs)
and
Investor.
Our
financials
allocation
rose
in
our
fiscal
year’s
second
half
following
two
large
purchases.
We
started
a
position
in
Lloyds
Banking
Group,
a
leading
UK
retail
bank
that
is
positioned
for
improved
earnings
growth
as
mortgage
demand
recovers
and
incomes
stabilize
in
Britain,
where
high
inflation
and
aggressive
interest
rate
hikes
have
sparked
a
cost-of-living
crisis
starting
in
late
2021.
We
also
initiated
Hiscox,
a
Bermuda-headquartered
nonlife
insurer
whose
various
business
units
are
benefiting
from
growth
tailwinds
that
we
believe
are
underappreciated
by
the
market.
Health
care
was
the
second-largest
allocation
in
absolute
terms
and
the
largest
overweight
sector
against
the
benchmark.
Our
health
care
holdings
are
focused
on
large-cap
pharmaceuticals
companies,
anchored
by
our
core
positions
in
Swiss
drugmaker
Roche
and
France’s
Sanofi.
We
also
maintained
exposure
to
the
health
care
equipment
and
supplies
industry
through
investments
such
as
UK
medical
device
maker
Smith
&
Nephew
and
France’s
EssilorLuxottica,
the
world’s
leading
eyewear
company.
One
of
our
largest
trades
in
health
care
in
the
period’s
second
half
was
starting
a
position
in
Japanese
medical
technology
company
Olympus.
Shares
of
Olympus,
the
world’s
leading
gastrointestinal
endoscopes
maker,
have
lagged
Japan’s
stock
market
after
the
company
received
PERFORMANCE
COMPARISON
Total
Return
Periods
Ended
10/31/23
6
Months
12
Months
Institutional
International
Disciplined
Equity
Fund
-9.70‌%
14.74‌%
MSCI
EAFE
Index
Net
-7.88‌
14.40‌
Lipper
International
Multi-Cap
Core
Funds
Average
-6.81‌
13.72‌
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
3
warning
letters
from
U.S.
regulators
for
violating
medical
device
reporting
requirements,
in
addition
to
other
company-
specific
setbacks.
However,
we
think
that
management
is
taking
the
right
steps
to
resolve
the
regulatory
issues
and
that
Olympus
can
deliver
better-than-expected
earnings
in
the
coming
years
driven
by
new
product
launches.
Industrials
and
business
services
was
the
largest
underweight
sector
at
fiscal
year-end
despite
representing
a
sizable
allocation
on
an
absolute
basis.
Our
holdings
are
mostly
industrial
conglomerates
such
as
Germany’s
Siemens,
Hong
Kong-based
CK
Hutchison,
and
UK
engineering
company
Smiths
Group,
though
we
maintained
a
modest
overweight
to
electrical
equipment
names
through
our
positions
in
Mitsubishi
Electric
and
Schneider
Electric.
Major
trades
in
the
past
six
months
included
eliminating
our
holding
in
Knorr-
Bremse,
a
German
manufacturer
of
brakes
and
safety
systems
for
trains
and
commercial
vehicles,
due
to
our
concerns
about
the
company’s
limited
near-term
growth
catalysts
and
significant
exposure
to
China.
We
also
eliminated
Japanese
trading
company
Mitsubishi,
whose
shares
rose
to
a
record
in
May
after
it
announced
a
large
share
buyback
plan.
Although
Japan’s
trading
companies
have
benefited
from
surging
commodity
prices
and
the
weak
yen,
we
reasoned
that
an
eventual
commodity
prices
downturn
would
weigh
on
earnings
for
Mitsubishi,
whose
commodities
exposure
is
higher
than
most
of
its
peers.
Our
exposure
to
the
machinery
and
trading
companies
fell
to
zero
following
these
trades,
allowing
us
to
fund
higher-conviction
names
in
the
sector.
We
started
a
new
position
in
Smiths
Group,
whose
products
range
from
oil
pipeline
seals
to
airport
security
scanners.
Despite
underperforming
its
peers
over
many
years,
Smiths
Group
has
a
portfolio
of
solid
assets
and
strong
growth
tailwinds
in
several
end
markets,
and
we
think
it
is
positioned
for
a
turnaround
under
a
new
chief
executive
who
took
over
in
2021.
What
is
portfolio
management’s
outlook?
International
stock
markets
appear
to
be
trying
to
decide
whether
the
global
economy
will
fall
into
a
recession
in
the
near
term.
Countervailing
forces
(i.e.,
higher
interest
rates,
souring
consumer
confidence,
and
sagging
purchasing
managers
indexes
on
the
one
hand
and
a
resilient
labor
market,
moderating
core
inflation
in
the
U.S.,
a
better
commodity
price
environment,
and
improved
third-quarter
earnings
on
the
other)
have
made
that
call
increasingly
challenging.
Valuations
appear
to
be
pricing
in
a
soft
landing
with
greater
certainty.
However,
we
would
caution
against
dismissing
the
possibility
that
central
banks
keep
rates
higher
for
longer,
something
that
is
not
currently
priced
into
stocks.
As
active
managers,
we
believe
that
bottom-up
stock
picking
is
more
important
than
making
the
correct
macro
bet
for
long-
term
investing
success,
particularly
in
times
of
high
uncertainty.
But
we
also
think
that
investors
should
“mind
the
gap”
in
the
inverted
Treasury
yield
curve
(a
closely
watched
barometer
of
recession
risk)
and
other
distress
signals
(e.g.,
deteriorating
credit
conditions
for
banks
and
the
risk
of
U.S.
consumers
faltering).
SECTOR
DIVERSIFICATION
Percent
of
Net
Assets
4/30/23
10/31/23
Financials
18.3‌%
19.7‌%
Health
Care
15.7‌ 
16.4‌ 
Consumer
Staples
11.4‌ 
12.9‌ 
Industrials
and
Business
Services
13.2‌ 
12.2‌ 
Consumer
Discretionary
9.1‌ 
8.6‌ 
Materials
8.4‌ 
8.4‌ 
Information
Technology
4.8‌ 
5.4‌ 
Utilities
3.1‌ 
3.6‌ 
Energy
2.9‌ 
3.4‌ 
Real
Estate
3.5‌ 
1.9‌ 
Communication
Services
2.3‌ 
1.0‌ 
Other
and
Reserves
7.3‌ 
6.5‌ 
Total
100.0‌%
100.0‌%
Historical
weightings
reflect
current
industry/sector
classifications.
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
4
We
are
committed
to
executing
our
disciplined
investment
strategy
and
remain
focused
on
exploiting
opportunities
created
by
the
market’s
inefficiencies.
Our
view
that
fundamentally
sound,
low-beta
stocks
can
buck
the
trend
of
an
overall
market
derating
is
unchanged.
We
continue
to
apply
a
disciplined,
absolute
valuation
framework—underpinned
by
bottom-up
stock
selection,
fundamental
research,
and
an
awareness
of
macro
conditions—in
our
pursuit
of
generating
strong,
risk-adjusted
performance
for
our
shareholders.
The
views
expressed
reflect
the
opinions
of
T.
Rowe
Price
as
of
the
date
of
this
report
and
are
subject
to
change
based
on
changes
in
market,
economic,
or
other
conditions.
These
views
are
not
intended
to
be
a
forecast
of
future
events
and
are
no
guarantee
of
future
results.
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
5
PRINCIPAL
RISKS
International
investing.
Investing
in
the
securities
of
non-U.S.
issuers
involves
special
risks
not
typically
associated
with
investing
in
U.S.
issuers.
Non-U.S.
securities
tend
to
be
more
volatile
and
have
lower
overall
liquidity
than
investments
in
U.S.
securities
and
may
lose
value
because
of
adverse
local,
political,
social,
or
economic
developments
overseas,
or
due
to
changes
in
the
exchange
rates
between
foreign
currencies
and
the
U.S.
dollar.
In
addition,
investments
outside
the
U.S.
are
subject
to
settlement
practices
and
regulatory
and
financial
reporting
standards
that
differ
from
those
of
the
U.S.
The
risks
of
investing
outside
the
U.S.
are
heightened
for
any
investments
in
emerging
markets,
which
are
susceptible
to
greater
volatility
than
investments
in
developed
markets.
Market
conditions.
The
value
of
the
fund’s
investments
may
decrease,
sometimes
rapidly
or
unexpectedly,
due
to
factors
affecting
an
issuer
held
by
the
fund,
particular
industries,
or
the
overall
securities
markets.
A
variety
of
factors
can
increase
the
volatility
of
the
fund’s
holdings
and
markets
generally,
including
political
or
regulatory
developments,
recessions,
inflation,
rapid
interest
rate
changes,
war
or
acts
of
terrorism,
natural
disasters,
and
outbreaks
of
infectious
illnesses
or
other
widespread
public
health
issues
such
as
the
coronavirus
pandemic
and
related
governmental
and
public
responses.
Certain
events
may
cause
instability
across
global
markets,
including
reduced
liquidity
and
disruptions
in
trading
markets,
while
some
events
may
affect
certain
geographic
regions,
countries,
sectors,
and
industries
more
significantly
than
others.
Government
intervention
in
markets
may
impact
interest
rates,
market
volatility,
and
security
pricing.
These
adverse
developments
may
cause
broad
declines
in
market
value
due
to
short-term
market
movements
or
for
significantly
longer
periods
during
more
prolonged
market
downturns.
BENCHMARK
INFORMATION
Note:
Portions
of
the
mutual
fund
information
contained
in
this
report
was
supplied
by
Lipper,
a
Refinitiv
Company,
subject
to
the
following:
Copyright
2023
©
Refinitiv.
All
rights
reserved.
Any
copying,
republication
or
redistribution
of
Lipper
content
is
expressly
prohibited
without
the
prior
written
consent
of
Lipper.
Lipper
shall
not
be
liable
for
any
errors
or
delays
in
the
content,
or
for
any
actions
taken
in
reliance
thereon.
Note:
MSCI
and
its
affiliates
and
third-party
sources
and
providers
(collectively,
“MSCI”)
makes
no
express
or
implied
warranties
or
representations
and
shall
have
no
liability
whatsoever
with
respect
to
any
MSCI
data
contained
herein.
The
MSCI
data
may
not
be
further
redistributed
or
used
as
a
basis
for
other
indices
or
any
securities
or
financial
products.
This
report
is
not
approved,
reviewed,
or
produced
by
MSCI.
Historical
MSCI
data
and
analysis
should
not
be
taken
as
an
indication
or
guarantee
of
any
future
performance
analysis,
forecast
or
prediction.
None
of
the
MSCI
data
is
intended
to
constitute
investment
advice
or
a
recommendation
to
make
(or
refrain
from
making)
any
kind
of
investment
decision
and
may
not
be
relied
on
as
such.
TWENTY-FIVE
LARGEST
HOLDINGS
Company
Country
Percent
of
Net
Assets
10/31/23
Groupe
Bruxelles
Lambert
Belgium
2.0‌%
Nestle
Switzerland
2.0‌ 
Roche
Holding
Switzerland
2.0‌ 
Euronext
France
1.8‌ 
TotalEnergies
France
1.7‌ 
ASML
Holding
Netherlands
1.7‌ 
Shell
United
Kingdom
1.6‌ 
Siemens
Germany
1.6‌ 
Smith
&
Nephew
United
Kingdom
1.6‌ 
Cie
Financiere
Richemont
Switzerland
1.6‌ 
Barry
Callebaut
Switzerland
1.5‌ 
Shimano
Japan
1.5‌ 
HAL
Trust
Netherlands
1.5‌ 
Amadeus
IT
Group
Spain
1.5‌ 
Kao
Japan
1.5‌ 
Volkswagen
Germany
1.4‌ 
Unilever
United
Kingdom
1.4‌ 
Smiths
Group
United
Kingdom
1.4‌ 
Heineken
Netherlands
1.4‌ 
Eurofins
Scientific
France
1.4‌ 
Suntory
Beverage
&
Food
Japan
1.4‌ 
Investor
Sweden
1.4‌ 
L
E
Lundbergforetagen
Sweden
1.4‌ 
Sanofi
France
1.4‌ 
Industrivarden
Sweden
1.4‌ 
Total
39.1‌%
Note:
The
information
shown
does
not
reflect
any
exchange-traded
funds
(ETFs),
cash
reserves,
or
collateral
for
securities
lending
that
may
be
held
in
the
portfolio.
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
6
GROWTH
OF
$1
MILLION 
This
chart
shows
the
value
of
a
hypothetical
$1
million
investment
in
the
fund
over
the
past
10
fiscal
year
periods
or
since
inception
(for funds
lacking
10-year
records).
The
result
is
compared
with
benchmarks,
which
include
a
broad-based
market
index
and
may
also
include
a
peer
group
average
or
index.
Market
indexes
do
not
include
expenses,
which
are
deducted
from
fund returns
as
well
as
mutual fund
averages
and
indexes.
INSTITUTIONAL
INTERNATIONAL
DISCIPLINED
EQUITY
FUND
AVERAGE
ANNUAL
COMPOUND
TOTAL
RETURN
EXPENSE
RATIO
FUND
EXPENSE
EXAMPLE
As
a
mutual
fund
shareholder,
you
may
incur
two
types
of
costs:
(1)
transaction
costs,
such
as
redemption
fees
or
sales
loads,
and
(2)
ongoing
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
fund
expenses.
The
following
example
is
intended
to
help
you
understand
your
ongoing
costs
(in
dollars)
of
investing
in
the
fund
and
to
compare
these
costs
with
the
ongoing
costs
of
investing
in
other
mutual
funds.
The
example
is
based
on
an
investment
of
$1,000
invested
at
the
beginning
of
the
most
recent
six-month
period
and
held
for
the
entire
period.
Actual
Expenses
The
first
line
of
the
following
table
(Actual)
provides
information
about
actual
account
values
and
actual
expenses.
You
may
use
the
information
on
this
line,
together
with
your
account
balance,
to
estimate
the
expenses
that
you
paid
over
the
period.
Simply
divide
your
account
value
by
$1,000
(for
example,
an
$8,600
account
value
divided
by
$1,000
=
8.6),
then
multiply
the
result
by
the
number
on
the
first
line
under
the
heading
“Expenses
Paid
During
Period”
to
estimate
the
expenses
you
paid
on
your
account
during
this
period.
Hypothetical
Example
for
Comparison
Purposes
The
information
on
the
second
line
of
the
table
(Hypothetical)
is
based
on
hypothetical
account
values
and
expenses
derived
from
the
fund’s
actual
expense
ratio
and
an
assumed
5%
per
year
rate
of
return
before
expenses
(not
the
fund’s
actual
return).
You
may
compare
the
ongoing
costs
of
investing
in
the
fund
with
other
funds
by
contrasting
this
5%
hypothetical
example
and
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
the
other
funds.
The
hypothetical
account
values
and
expenses
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period.
You
should
also
be
aware
that
the
expenses
shown
in
the
table
highlight
only
your
ongoing
costs
and
do
not
reflect
any
transaction
costs,
such
as
redemption
fees
or
sales
loads.
Therefore,
the
second
line
of
the
table
is
useful
in
comparing
ongoing
costs
only
and
will
not
help
you
determine
the
relative
total
costs
of
owning
different
funds.
To
the
extent
a
fund
charges
transaction
costs,
however,
the
total
cost
of
owning
that
fund
is
higher.
INSTITUTIONAL
INTERNATIONAL
DISCIPLINED
EQUITY
FUND
Periods
Ended
10/31/23
1
Year
5
Years
10
Years
Institutional
International
Disciplined
Equity
Fund
14.74‌%
3.82‌%
3.52‌%
This
table
shows
how
the
fund
would
have
performed
each
year
if
its
actual
(or
cumulative)
returns
for
the
periods
shown
had
been
earned
at
a
constant
rate.
Returns
do
not
reflect
taxes
that
the
shareholder
may
pay
on
fund
distributions
or
the
redemption
of
fund
shares.
Past
performance
cannot
guarantee
future
results.
Institutional
International
Disciplined
Equity
Fund
0.78‌%
The
expense
ratio
shown
is
as
of
the
fund’s
most
recent
prospectus.
This
number
may
vary
from
the
expense
ratio
shown
elsewhere
in
this
report
because
it
is
based
on
a
different
time
period
and,
if
applicable,
includes
acquired
fund
fees
and
expenses
but
does
not
include
fee
or
expense
waivers.
Beginning
Account
Value
5/1/23
Ending
Account
Value
10/31/23
Expenses
Paid
During
Period*
5/1/23
to
10/31/23
Actual
$1,000.00
$903.00
$3.60
Hypothetical
(assumes
5%
return
before
expenses)
 1,000.00
  1,021.42
  3.82
*
Expenses
are
equal
to
the
fund’s
annualized
expense
ratio
for
the
6-month
period
(0.75%),
multiplied
by
the
average
account
value
over
the
period,
multiplied
by
the
number
of
days
in
the
most
recent
fiscal
half
year
(184),
and
divided
by
the
days
in
the
year
(365)
to
reflect
the
half-year
period.
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
7
QUARTER-END
RETURNS
Periods
Ended
9/30/23
1
Year
5
Years
10
Years
Institutional
International
Disciplined
Equity
Fund
23.29‌%
2.99‌%
4.25‌%
The
fund’s
performance
information
represents
only
past
performance
and
is
not
necessarily
an
indication
of
future
results.
Current
performance
may
be
lower
or
higher
than
the
performance
data
cited.
Share
price,
principal
value,
and
return
will
vary,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
For
the
most
recent
month-
end
performance,
please
contact
a
T.
Rowe
Price
representative
at
1-800-638-8790.
This
table
provides
returns
net
of
expenses
through
the
most
recent
calendar
quarter-end
rather
than
through
the
end
of
the
fund’s
fiscal
period.
It
shows
how
the
fund
would
have
performed
each
year
if
its
actual
(or
cumulative)
returns
for
the
periods
shown
had
been
earned
at
a
constant
rate.
Average
annual
total
return
figures
include
changes
in
principal
value,
reinvested
dividends,
and
capital
gain
distributions.
Returns
do
not
reflect
taxes
that
the
shareholder
may
pay
on
fund
distributions
or
the
redemption
of
fund
shares.
When
assessing
performance,
investors
should
consider
both
short-
and
long-term
returns.
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
Financial
Highlights
8
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
..
Year
..
..
Ended
.
10/31/23
10/31/22
10/31/21
10/31/20
10/31/19
NET
ASSET
VALUE
Beginning
of
period
$
9.66‌
$
12.67‌
$
10.09‌
$
11.52‌
$
12.04‌
Investment
activities
Net
investment
income
(1)(2)
0.25‌
0.21‌
0.17‌
0.21‌
0.24‌
Net
realized
and
unrealized
gain/loss
1.17‌
(2.84‌)
2.73‌
(1.22‌)
1.11‌
Total
from
investment
activities
1.42‌
(2.63‌)
2.90‌
(1.01‌)
1.35‌
Distributions
Net
investment
income
(0.09‌)
(0.16‌)
(0.20‌)
(0.28‌)
(0.42‌)
Net
realized
gain
–‌
(0.22‌)
(0.12‌)
(0.14‌)
(1.45‌)
Total
distributions
(0.09‌)
(0.38‌)
(0.32‌)
(0.42‌)
(1.87‌)
NET
ASSET
VALUE
End
of
period
$
10.99‌
$
9.66‌
$
12.67‌
$
10.09‌
$
11.52‌
Ratios/Supplemental
Data
Total
return
(2)(3)
14.74‌%
(21.29‌)%
28.96‌%
(9.22‌)%
14.09‌%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/payments
by
Price
Associates
0.81‌%
0.78‌%
0.75‌%
0.75‌%
0.77‌%
Net
expenses
after
waivers/payments
by
Price
Associates
0.75‌%
0.75‌%
0.75‌%
0.75‌%
0.75‌%
Net
investment
income
2.16‌%
1.86‌%
1.37‌%
1.99‌%
2.22‌%
Portfolio
turnover
rate
93.8‌%
78.9‌%
81.1‌%
86.0‌%
93.3‌%
Net
assets,
end
of
period
(in
thousands)
$
187,136‌
$
248,843‌
$
373,224‌
$
268,221‌
$
288,289‌
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
See
Note
6
for
details
of
expense-related
arrangements
with
Price
Associates.
(3)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
October
31,
2023
9
Portfolio
of
Investments
Shares
$
Value
(
Cost
and
value
in
$000s)
AUSTRALIA
1.4%
Common
Stocks
1.4%
BHP
Group
(GBP) 
89,779‌
2,553‌
Total
Australia
(Cost
$1,031
)
2,553‌
BELGIUM
2.0%
Common
Stocks
2.0%
Groupe
Bruxelles
Lambert 
52,101‌
3,811‌
Total
Belgium
(Cost
$4,061
)
3,811‌
CANADA
3.5%
Common
Stocks
3.5%
Brookfield 
83,600‌
2,436‌
Mainstreet
Equity  (1)
19,251‌
1,871‌
Power
Corp.
of
Canada 
90,400‌
2,178‌
Total
Canada
(Cost
$6,580
)
6,485‌
DENMARK
1.2%
Common
Stocks
1.2%
Novozymes,
Class
49,896‌
2,242‌
Total
Denmark
(Cost
$2,496
)
2,242‌
FINLAND
1.3%
Common
Stocks
1.3%
Fortum 
202,952‌
2,410‌
Total
Finland
(Cost
$2,621
)
2,410‌
FRANCE
10.0%
Common
Stocks
10.0%
EssilorLuxottica 
12,858‌
2,328‌
Eurofins
Scientific 
52,593‌
2,668‌
Euronext 
47,562‌
3,317‌
Sanofi 
28,966‌
2,630‌
Schneider
Electric 
14,186‌
2,183‌
TotalEnergies 
48,769‌
3,261‌
Wendel 
32,399‌
2,427‌
Total
France
(Cost
$16,753
)
18,814‌
GERMANY
8.2%
Common
Stocks
5.5%
BASF 
55,102‌
2,546‌
Bayer 
56,270‌
2,431‌
Continental 
34,215‌
2,234‌
Siemens 
22,492‌
2,985‌
10,196‌
Preferred
Stocks
2.7%
Henkel 
33,315‌
2,403‌
Shares
$
Value
(Cost
and
value
in
$000s)
Volkswagen 
25,535‌
2,708‌
5,111‌
Total
Germany
(Cost
$15,575
)
15,307‌
HONG
KONG
2.7%
Common
Stocks
2.7%
CK
Hutchison
Holdings 
481,192‌
2,436‌
Jardine
Matheson
Holdings
(USD) 
63,200‌
2,561‌
Total
Hong
Kong
(Cost
$6,085
)
4,997‌
JAPAN
19.1%
Common
Stocks
19.1%
Hamamatsu
Photonics 
67,600‌
2,511‌
Hoshizaki 
73,800‌
2,383‌
Hoya 
19,300‌
1,858‌
Kao 
74,400‌
2,714‌
Kirin
Holdings 
173,800‌
2,443‌
Mitsubishi
Electric 
207,100‌
2,375‌
Nippon
Sanso
Holdings 
76,400‌
1,927‌
Nippon
Telegraph
&
Telephone 
1,663,100‌
1,957‌
Olympus 
192,700‌
2,574‌
Otsuka
Holdings 
73,200‌
2,463‌
Shimadzu 
106,600‌
2,521‌
Shimano 
19,500‌
2,806‌
Sony
Group 
31,000‌
2,577‌
Suntory
Beverage
&
Food 
88,500‌
2,663‌
Tokyo
Electron 
14,600‌
1,929‌
Total
Japan
(Cost
$35,585
)
35,701‌
NETHERLANDS
8.2%
Common
Stocks
8.2%
ASML
Holding 
5,254‌
3,158‌
DSM-Firmenich 
22,212‌
2,014‌
EXOR 
29,436‌
2,526‌
HAL
Trust 
24,817‌
2,795‌
Heineken 
29,702‌
2,669‌
Koninklijke
Philips  (1)
112,272‌
2,136‌
Total
Netherlands
(Cost
$12,949
)
15,298‌
NORWAY
1.1%
Common
Stocks
1.1%
Storebrand 
247,685‌
2,068‌
Total
Norway
(Cost
$2,009
)
2,068‌
PHILIPPINES
1.4%
Common
Stocks
1.4%
Ayala 
241,410‌
2,581‌
Total
Philippines
(Cost
$3,400
)
2,581‌
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
10
Shares
$
Value
(Cost
and
value
in
$000s)
SPAIN
2.7%
Common
Stocks
2.7%
Amadeus
IT
Group 
47,923‌
2,735‌
Iberdrola 
206,836‌
2,301‌
Total
Spain
(Cost
$4,671
)
5,036‌
SWEDEN
4.2%
Common
Stocks
4.2%
Industrivarden,
Class
101,596‌
2,620‌
Investor,
Class
144,877‌
2,660‌
L
E
Lundbergforetagen,
Class
64,623‌
2,639‌
Total
Sweden
(Cost
$6,121
)
7,919‌
SWITZERLAND
8.4%
Common
Stocks
8.4%
Barry
Callebaut 
1,889‌
2,864‌
Cie
Financiere
Richemont 
24,955‌
2,944‌
Nestle 
34,185‌
3,687‌
Novartis 
27,562‌
2,580‌
Roche
Holding 
14,210‌
3,662‌
Total
Switzerland
(Cost
$13,801
)
15,737‌
UNITED
KINGDOM
18.1%
Common
Stocks
18.1%
Anglo
American 
101,336‌
2,582‌
Diageo 
54,463‌
2,059‌
Experian 
85,631‌
2,598‌
Great
Portland
Estates 
347,291‌
1,649‌
GSK 
134,259‌
2,393‌
Hiscox 
221,050‌
2,524‌
HSBC
Holdings 
316,840‌
2,288‌
Lloyds
Banking
Group 
5,173,890‌
2,518‌
Shares
$
Value
(Cost
and
value
in
$000s)
Mondi 
116,590‌
1,886‌
National
Grid 
177,404‌
2,115‌
Shell 
93,547‌
3,015‌
Smith
&
Nephew 
264,637‌
2,962‌
Smiths
Group 
137,264‌
2,692‌
Unilever
(EUR) 
57,013‌
2,697‌
Total
United
Kingdom
(Cost
$35,309
)
33,978‌
UNITED
STATES
1.5%
Exchange-Traded
Funds
1.5%
iShares
MSCI
EAFE
ETF  (2)
41,800‌
2,797‌
Total
United
States
(Cost
$2,861
)
2,797‌
SHORT-TERM
INVESTMENTS
3.3%
Money
Market
Funds
3.3%
T.
Rowe
Price
Government
Reserve
Fund,
5.42%  (3)(4)
6,161,983‌
6,162‌
Total
Short-Term
Investments
(Cost
$6,162)
6,162‌
SECURITIES
LENDING
COLLATERAL
0.2%
INVESTMENTS
IN
A
POOLED
ACCOUNT
THROUGH
SECURITIES
LENDING
PROGRAM
WITH
JPMORGAN
CHASE
BANK
0.2%
Money
Market
Funds
0.2%
T.
Rowe
Price
Government
Reserve
Fund,
5.42%  (3)(4)
388,169‌
388‌
Total
Investments
in
a
Pooled
Account
through
Securities
Lending
Program
with
JPMorgan
Chase
Bank
388‌
Total
Securities
Lending
Collateral
(Cost
$388)
388‌
Total
Investments
in
Securities
98.5%
of
Net
Assets
(Cost
$178,458)
$
184,284‌
Country
classifications
are
generally
based
on
MSCI
categories
or
another
unaffiliated
third
party
data
provider;
Shares
are
denominated
in
the
currency
of
the
country
presented
unless
otherwise
noted.
(1)
Non-income
producing
(2)
See
Note
3
.
All
or
a
portion
of
this
security
is
on
loan
at
October
31,
2023.
(3)
Seven-day
yield
(4)
Affiliated
Companies
ETF
Exchange-Traded
Fund
EUR
Euro
GBP
British
Pound
USD
U.S.
Dollar
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
11
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
year
ended
October
31,
2023.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
T.
Rowe
Price
Government
Reserve
Fund,
5.42%
$
—‌
$
—‌
$
427‌++
Totals
$
—‌#
$
—‌
$
427‌+
Supplementary
Investment
Schedule
Affiliate
Value
10/31/22
Purchase
Cost
Sales
Cost
Value
10/31/23
T.
Rowe
Price
Government
Reserve
Fund,
5.42%
$
16,332‌
 ¤
  ¤
$
6,550‌
Total
$
6,550‌^
#
Capital
gain
distributions
from
underlying
Price
funds
represented
$0
of
the
net
realized
gain
(loss).
++
Excludes
earnings
on
securities
lending
collateral,
which
are
subject
to
rebates
and
fees
as
described
in
Note
3
.
+
Investment
income
comprised
$427
of
dividend
income
and
$0
of
interest
income.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$6,550.
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
October
31,
2023
Statement
of
Assets
and
Liabilities
12
($000s,
except
shares
and
per
share
amounts)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Assets
Investments
in
securities,
at
value
(cost
$178,458)
$
184,284‌
Receivable
for
investment
securities
sold
1,345‌
Dividends
receivable
238‌
Foreign
currency
(cost
$88)
87‌
Receivable
for
shares
sold
54‌
Due
from
affiliates
1‌
Other
assets
2,546‌
Total
assets
188,555‌
Liabilities
Payable
for
investment
securities
purchased
679‌
Obligation
to
return
securities
lending
collateral
509‌
Investment
management
fees
payable
105‌
Payable
for
shares
redeemed
78‌
Other
liabilities
48‌
Total
liabilities
1,419‌
NET
ASSETS
$
187,136‌
Net
Assets
Consist
of:
Total
distributable
earnings
(loss)
$
(9,695‌)
Paid-in
capital
applicable
to
17,021,943
shares
of
$0.01
par
value
capital
stock
outstanding;
1,000,000,000
shares
of
the
Corporation
authorized
196,831‌
NET
ASSETS
$
187,136‌
NET
ASSET
VALUE
PER
SHARE
$
10.99‌
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
Statement
of
Operations
13
($000s)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Year
Ended
10/31/23
Investment
Income
(Loss)
Income
Dividend
(net
of
foreign
taxes
of
$606)
$
6,180‌
Securities
lending
35‌
Total
income
6,215‌
Expenses
Investment
management
1,391‌
Shareholder
servicing
2‌
Prospectus
and
shareholder
reports
18‌
Custody
and
accounting
215‌
Legal
and
audit
49‌
Registration
40‌
Proxy
and
annual
meeting
4‌
Directors
1‌
Miscellaneous
13‌
Waived
/
paid
by
Price
Associates
(129‌)
Total
expenses
1,604‌
Net
investment
income
4,611‌
Realized
and
Unrealized
Gain
/
Loss  
Net
realized
gain
(loss)
Securities
9,278‌
Foreign
currency
transactions
14‌
Net
realized
gain
9,292‌
Change
in
net
unrealized
gain
/
loss
Securities
23,226‌
Other
assets
and
liabilities
denominated
in
foreign
currencies
182‌
Change
in
net
unrealized
gain
/
loss
23,408‌
Net
realized
and
unrealized
gain
/
loss
32,700‌
INCREASE
IN
NET
ASSETS
FROM
OPERATIONS
$
37,311‌
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
Statement
of
Changes
in
Net
Assets
14
($000s)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Year
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Ended
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
10/31/23
10/31/22
Increase
(Decrease)
in
Net
Assets
Operations
Net
investment
income
$
4,611‌
$
5,991‌
Net
realized
gain
(loss)
9,292‌
(13,402‌)
Change
in
net
unrealized
gain
/
loss
23,408‌
(67,869‌)
Increase
(decrease)
in
net
assets
from
operations
37,311‌
(75,280‌)
Distributions
to
shareholders
Net
earnings
(1,762‌)
(11,465‌)
Capital
share
transactions
*
Shares
sold
25,765‌
59,703‌
Distributions
reinvested
1,518‌
10,305‌
Shares
redeemed
(124,539‌)
(107,644‌)
Decrease
in
net
assets
from
capital
share
transactions
(97,256‌)
(37,636‌)
Net
Assets
Decrease
during
period
(61,707‌)
(124,381‌)
Beginning
of
period
248,843‌
373,224‌
End
of
period
$
187,136‌
$
248,843‌
*Share
information
(000s)
Shares
sold
2,258‌
5,139‌
Distributions
reinvested
143‌
879‌
Shares
redeemed
(11,134‌)
(9,719‌)
Decrease
in
shares
outstanding
(8,733‌)
(3,701‌)
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
15
NOTES
TO
FINANCIAL
STATEMENTS
T.
Rowe
Price
Global
Funds,
Inc.
(the
corporation) is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act).
The
Institutional
International
Disciplined
Equity
Fund
(the
fund)
is a
diversified, open-end
management
investment
company
established
by
the
corporation. The
fund
seeks
long-term
growth
of
capital
through
investments
in
stocks
of
non-U.S.
companies.
NOTE
1
-
SIGNIFICANT
ACCOUNTING
POLICIES 
Basis
of
Preparation
 The fund
is
an
investment
company
and
follows
accounting
and
reporting
guidance
in
the
Financial
Accounting
Standards
Board
(FASB)
Accounting
Standards
Codification
Topic
946
(ASC
946).
The
accompanying
financial
statements
were
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP),
including,
but
not
limited
to,
ASC
946.
GAAP
requires
the
use
of
estimates
made
by
management.
Management
believes
that
estimates
and
valuations
are
appropriate;
however,
actual
results
may
differ
from
those
estimates,
and
the
valuations
reflected
in
the
accompanying
financial
statements
may
differ
from
the
value
ultimately
realized
upon
sale
or
maturity.
Investment
Transactions,
Investment
Income,
and
Distributions
 Investment
transactions
are
accounted
for
on
the
trade
date
basis.
Income
and
expenses
are
recorded
on
the
accrual
basis.
Realized
gains
and
losses
are
reported
on
the
identified
cost
basis.
 Income
tax-related
interest
and
penalties,
if
incurred,
are
recorded
as
income
tax
expense.
 Dividends
received
from other
investment
companies are
reflected
as
dividend
income;
capital
gain
distributions
are
reflected
as
realized
gain/loss.
 Dividend
income and
capital
gain
distributions
are
recorded
on
the
ex-dividend
date.
 Non-cash
dividends,
if
any,
are
recorded
at
the
fair
market
value
of
the
asset
received.
 Proceeds
from
litigation
payments,
if
any,
are
included
in
either
net
realized
gain
(loss)
or
change
in
net
unrealized
gain/
loss
from
securities.
 Distributions
to
shareholders
are
recorded
on
the
ex-dividend
date.
 Income
distributions,
if
any,
are
declared
and
paid annually.
 A
capital
gain
distribution,
if
any, may
also
be
declared
and
paid
by
the
fund
annually.
Currency
Translation
 Assets,
including
investments,
and
liabilities
denominated
in
foreign
currencies
are
translated
into
U.S.
dollar
values
each
day
at
the
prevailing
exchange
rate,
using
the
mean
of
the
bid
and
asked
prices
of
such
currencies
against
U.S.
dollars
as
provided
by
an
outside
pricing
service.
Purchases
and
sales
of
securities,
income,
and
expenses
are
translated
into
U.S.
dollars
at
the
prevailing
exchange
rate
on
the
respective
date
of
such
transaction.
The
effect
of
changes
in
foreign
currency
exchange
rates
on
realized
and
unrealized
security
gains
and
losses
is
not
bifurcated
from
the
portion
attributable
to
changes
in
market
prices.
Capital
Transactions
 Each
investor’s
interest
in
the
net
assets
of the
fund
is
represented
by
fund
shares. The
fund’s
net
asset
value
(NAV)
per
share
is
computed
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
ET,
each
day
the
NYSE
is
open
for
business.
However,
the
NAV
per
share
may
be
calculated
at
a
time
other
than
the
normal
close
of
the
NYSE
if
trading
on
the
NYSE
is
restricted,
if
the
NYSE
closes
earlier,
or
as
may
be
permitted
by
the
SEC.
Purchases
and
redemptions
of
fund
shares
are
transacted
at
the
next-computed
NAV
per
share,
after
receipt
of
the
transaction
order
by
T.
Rowe
Price
Associates,
Inc.,
or
its
agents.
New
Accounting
Guidance
 In
June
2022,
the
FASB
issued
Accounting
Standards
Update
(ASU),
ASU
2022-03,
Fair
Value
Measurement
(Topic
820)
Fair
Value
Measurement
of
Equity
Securities
Subject
to
Contractual
Sale
Restrictions,
which
clarifies
that
a
contractual
restriction
on
the
sale
of
an
equity
security
is
not
considered
part
of
the
unit
of
account
of
the
equity
security
and,
therefore,
is
not
considered
in
measuring
fair
value.
The
amendments
under
this
ASU
are
effective
for
fiscal
years
beginning
after
December
15,
2023;
however,
the
fund
opted
to
early
adopt,
as
permitted,
effective
December
1,
2022. Adoption
of
the
guidance
did not
have
a
material
impact
on
the fund's
financial  statements.
Indemnification
 In
the
normal
course
of
business, the
fund
may
provide
indemnification
in
connection
with
its
officers
and
directors,
service
providers,
and/or
private
company
investments. The
fund’s
maximum
exposure
under
these
arrangements
is
unknown;
however,
the
risk
of
material
loss
is
currently
considered
to
be
remote.
NOTE
2
-
VALUATION 
Fair
Value
  The
fund’s
financial
instruments
are
valued
at
the
close
of
the
NYSE
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The fund’s
Board
of
Directors
(the
Board)
has
designated
T.
Rowe
Price
Associates,
Inc.
as
the
fund’s
valuation
designee
(Valuation
Designee).
Subject
to
oversight
by
the
Board,
the
Valuation
Designee
performs
the
following
functions
in
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
16
performing
fair
value
determinations:
assesses
and
manages
valuation
risks;
establishes
and
applies
fair
value
methodologies;
tests
fair
value
methodologies;
and
evaluates
pricing
vendors
and
pricing
agents.
The
duties
and
responsibilities
of
the
Valuation
Designee
are
performed
by
its
Valuation
Committee. The
Valuation
Designee provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
Level
2
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
Level
3
unobservable
inputs
(including
the Valuation
Designee’s assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
Valuation
Techniques 
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities
and
the
last
quoted
sale
or
closing
price
for
international
securities.
The
last
quoted
prices
of
non-U.S.
equity
securities
may
be
adjusted
to
reflect
the
fair
value
of
such
securities
at
the
close
of
the
NYSE,
if
the Valuation
Designee
determines
that
developments
between
the
close
of
a
foreign
market
and
the
close
of
the
NYSE
will
affect
the
value
of
some
or
all
of
the fund’s portfolio
securities.
Each
business
day,
the
Valuation
Designee uses
information
from
outside
pricing
services
to
evaluate
the
quoted
prices
of
portfolio
securities
and,
if
appropriate,
decide whether
it
is
necessary
to
adjust
quoted
prices
to
reflect
fair
value
by
reviewing
a
variety
of
factors,
including
developments
in
foreign
markets,
the
performance
of
U.S.
securities
markets,
and
the
performance
of
instruments
trading
in
U.S.
markets
that
represent
foreign
securities
and
baskets
of
foreign
securities. The Valuation
Designee
uses
outside
pricing
services
to
provide
it
with
quoted
prices
and
information
to
evaluate
or
adjust
those
prices.
The Valuation
Designee
cannot
predict
how
often
it
will
use
quoted
prices
and
how
often
it
will
determine
it
necessary
to
adjust
those
prices
to
reflect
fair
value.
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Assets
and
liabilities
other
than
financial
instruments,
including
short-term
receivables
and
payables,
are
carried
at
cost,
or
estimated
realizable
value,
if
less,
which
approximates
fair
value. 
Investments
for
which
market
quotations are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Designee.
The
Valuation
Designee
has
adopted
methodologies
for
determining
the
fair
value
of
investments
for
which
market
quotations
are
not
readily
available
or
deemed
unreliable,
including
the
use
of
other
pricing
sources.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Designee typically
will
afford
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Designee may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
on
a
regular
basis.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions. Fair
value
prices
determined
by
the
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
17
Valuation
Designee could
differ
from
those
of
other
market
participants,
and
it
is
possible
that
the
fair
value
determined
for
a
security
may
be
materially
different
from
the
value
that
could
be
realized
upon
the
sale
of
that
security.
Valuation
Inputs
  The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
October
31,
2023
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments):
NOTE
3
-
OTHER
INVESTMENT
TRANSACTIONS 
Consistent
with
its
investment
objective,
the
fund
engages
in
the
following
practices
to
manage
exposure
to
certain
risks
and/or
to
enhance
performance.
The
investment
objective,
policies,
program,
and
risk
factors
of
the
fund
are
described
more
fully
in
the
fund's
prospectus
and
Statement
of
Additional
Information.
Emerging
and
Frontier
Markets
 The fund
invests,
either
directly
or
through
investments
in
other
T.
Rowe
Price
funds,
in
securities
of
companies
located
in,
issued
by
governments
of,
or
denominated
in
or
linked
to
the
currencies
of
emerging
and
frontier
market
countries.
Emerging
markets,
and
to
a
greater
extent
frontier
markets, tend
to
have
economic
structures
that
are
less
diverse
and
mature,
less
developed
legal
and
regulatory
regimes,
and
political
systems
that
are
less
stable,
than
those
of
developed
countries.
These
markets
may
be
subject
to
greater
political,
economic,
and
social
uncertainty
and
differing
accounting
standards
and
regulatory
environments
that
may
potentially
impact
the
fund’s
ability
to
buy
or
sell
certain
securities
or
repatriate
proceeds
to
U.S.
dollars.
Emerging
markets
securities
exchanges
are
more
likely
to
experience
delays
with
the
clearing
and
settling
of
trades,
as
well
as
the
custody
of
holdings
by
local
banks,
agents,
and
depositories.
Such
securities
are
often
subject
to
greater
price
volatility,
less
liquidity,
and
higher
rates
of
inflation
than
U.S.
securities.
Investing
in
frontier
markets
is
typically
significantly
riskier
than
investing
in
other
countries,
including
emerging
markets.
Securities
Lending
 The fund
may
lend
its
securities
to
approved
borrowers
to
earn
additional
income.
Its
securities
lending
activities
are
administered
by
a
lending
agent
in
accordance
with
a
securities
lending
agreement.
Security
loans
generally
do
not
have
stated
maturity
dates,
and
the
fund
may
recall
a
security
at
any
time.
The
fund
receives
collateral
in
the
form
of
cash
or
U.S.
government
securities.
Collateral
is
maintained
over
the
life
of
the
loan
in
an
amount
not
less
than
the
value
of
loaned
securities;
any
additional
collateral
required
due
to
changes
in
security
values
is
delivered
to
the
fund
the
next
business
day.
Cash
collateral
is
invested
in
accordance
with
investment
guidelines
approved
by
fund
management.
Additionally,
the
lending
agent
indemnifies
the
fund
against
losses
resulting
from
borrower
default.
Although
risk
is
mitigated
by
the
collateral
and
indemnification,
the
fund
could
experience
a
delay
in
recovering
its
securities
and
a
possible
loss
of
income
or
value
if
the
borrower
fails
to
return
the
securities,
collateral
investments
decline
in
value,
and
the
lending
agent
fails
to
perform.
Securities
lending
revenue
consists
of
earnings
on
invested
collateral
and
borrowing
fees,
net
of
any
rebates
to
the
borrower,
compensation
to
the
lending
agent,
and
other
administrative
costs.
In
accordance
with
GAAP,
investments
made
with
cash
collateral
are
reflected
in
the
accompanying
financial
statements,
but
collateral
received
in
the
form
of
securities
is
not.
At
October
31,
2023,
the
value
of
loaned
securities
was
$492,000;
the
value
of
cash
collateral
and
related
investments
was
$509,000.
Other 
Purchases
and
sales
of
portfolio
securities
other
than
short-term securities
aggregated $190,361,000 and
$280,198,000,
respectively,
for
the
year ended
October
31,
2023.
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Common
Stocks
$
—‌
$
169,826‌
$
—‌
$
169,826‌
Exchange-Traded
Funds
2,797‌
—‌
—‌
2,797‌
Preferred
Stocks
—‌
5,111‌
—‌
5,111‌
Short-Term
Investments
6,162‌
—‌
—‌
6,162‌
Securities
Lending
Collateral
388‌
—‌
—‌
388‌
Total
$
9,347‌
$
174,937‌
$
—‌
$
184,284‌
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
18
NOTE
4
-
FEDERAL
INCOME
TAXES
Generally,
no
provision
for
federal
income
taxes
is
required
since
the
fund
intends
to
continue
to
qualify
as
a
regulated
investment
company
under
Subchapter
M
of
the
Internal
Revenue
Code
and
distribute
to
shareholders
all
of
its
taxable
income
and
gains.
Distributions
determined
in
accordance
with
federal
income
tax
regulations
may
differ
in
amount
or
character
from
net
investment
income
and
realized
gains
for
financial
reporting
purposes.
The fund
files
U.S.
federal,
state,
and
local
tax
returns
as
required. The
fund’s
tax
returns
are
subject
to
examination
by
the
relevant
tax
authorities
until
expiration
of
the
applicable
statute
of
limitations,
which
is
generally
three
years
after
the
filing
of
the
tax
return,
but
which
can
be
extended
to
six
years
in
certain
circumstances.
Tax
returns
for
open
years
have
incorporated
no
uncertain
tax
positions
that
require
a
provision
for
income
taxes.
Capital
accounts
within
the
financial
reporting
records
are
adjusted
for
permanent
book/tax
differences
to
reflect
tax
character
but
are
not
adjusted
for
temporary
differences.
The
permanent
book/tax
adjustments,
if
any,
have
no
impact
on
results
of
operations
or
net
assets.
The
permanent
book/tax
adjustments
relate
primarily
to
the
character
of
income
on
passive
foreign
investment
companies.
The
tax
character
of
distributions
paid
for
the
periods
presented
was
as
follows:
At
October
31,
2023,
the
tax-basis
cost
of
investments
(including
derivatives,
if
any)
and
gross
unrealized
appreciation
and
depreciation
were
as
follows:
At
October
31,
2023,
the
tax-basis
components
of
accumulated
net
earnings
(loss)
were
as
follows:
Temporary
differences
between
book-basis
and
tax-basis
components
of
total
distributable
earnings
(loss)
arise
when
certain
items
of
income,
gain,
or
loss
are
recognized
in
different
periods
for
financial
statement
purposes
versus
for
tax
purposes;
these
differences
will
reverse
in
a
subsequent
reporting
period.
The
temporary
differences
relate
primarily
to
the
deferral
of
losses
from
wash
sales
and
the
realization
of
gains/losses
on
passive
foreign
investment
companies.
The
loss
carryforwards
and
deferrals
primarily
relate
to
capital
loss
carryforwards.
Capital
loss
carryforwards
are
available
indefinitely
to
offset
future
realized
capital
gains.
NOTE
5
-
FOREIGN  TAXES
The
fund
is
subject
to
foreign
income
taxes
imposed
by
certain
countries
in
which
it
invests.
Additionally,
capital
gains
realized
upon
disposition
of
securities
issued
in
or
by
certain
foreign
countries
are
subject
to
capital
gains
tax
imposed
by
those
countries.
All
taxes
are
computed
in
accordance
with
the
applicable
foreign
tax
law,
and,
to
the
extent
permitted,
capital
losses
are
used
to
offset
capital
gains.
Taxes
attributable
to
income
are
accrued
by
the
fund
as
a
reduction
of
income.
Current
and
deferred
tax
expense
attributable
to
capital
($000s)
October
31,
2023
October
31,
2022
Ordinary
income
(including
short-term
capital
gains,
if
any)
$
1,762‌
$
11,465‌
($000s)
Cost
of
investments
$
193,831‌
Unrealized
appreciation
$
23,792‌
Unrealized
depreciation
(33,344‌)
Net
unrealized
appreciation
(depreciation)
$
(9,552‌)
($000s)
Undistributed
ordinary
income
$
4,987‌
Net
unrealized
appreciation
(depreciation)
(9,552‌)
Loss
carryforwards
and
deferrals
(5,130‌)
Total
distributable
earnings
(loss)
$
(9,695‌)
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
19
gains
is
reflected
as
a
component
of
realized
or
change
in
unrealized
gain/loss
on
securities
in
the
accompanying
financial
statements.
To
the
extent
that
the
fund
has
country
specific
capital
loss
carryforwards,
such
carryforwards
are
applied
against
net
unrealized
gains
when
determining
the
deferred
tax
liability.
Any
deferred
tax
liability
incurred
by
the
fund
is
included
in
either
Other
liabilities
or
Deferred
tax
liability
on
the
accompanying
Statement
of
Assets
and
Liabilities.
NOTE
6
-
RELATED
PARTY
TRANSACTIONS
The
fund
is
managed
by
T.
Rowe
Price
Associates,
Inc.
(Price
Associates),
a
wholly
owned
subsidiary
of
T.
Rowe
Price
Group,
Inc.
(Price
Group). Price
Associates
has
entered
into
a
sub-advisory
agreement(s)
with
one
or
more
of
its
wholly
owned
subsidiaries,
to
provide
investment
advisory
services
to
the
fund. 
The
investment
management
agreement
between
the
fund
and
Price
Associates
provides
for
an
annual
investment
management
fee
equal
to 0.65%
of
the
fund’s
average
daily
net
assets.
The
fee
is
computed
daily
and
paid
monthly.
The
fund
is subject
to
a
contractual
expense
limitation
through
the
expense
limitation
date
indicated
in
the
table
below.
During
the
limitation
period,
Price
Associates is required
to
waive
its
management
fee
and
pay
the
fund
for
any
expenses
(excluding
interest;
expenses
related
to
borrowings,
taxes,
and
brokerage;
non-recurring,
extraordinary
expenses;
and
acquired
fund
fees
and
expenses)
that
would
otherwise
cause
the
fund’s
ratio
of
annualized
total
expenses
to
average
net
assets
(net
expense
ratio)
to
exceed
its
expense
limitation.
The
fund
is
required
to
repay
Price
Associates
for
expenses
previously
waived/paid
to
the
extent
its
net
assets
grow
or
expenses
decline
sufficiently
to
allow
repayment
without
causing
the
fund’s
net
expense
ratio
(after
the
repayment
is
taken
into
account)
to
exceed
the
lesser
of:
(1)
the
expense
limitation
in
place
at
the
time
such
amounts
were
waived;
or
(2)
the
fund’s
current
expense
limitation. However,
no
repayment
will
be
made
more
than
three
years
after
the
date
of
a
payment
or
waiver.
Pursuant
to
this
agreement,
expenses
were waived/paid
by
and/or
repaid
to
Price
Associates
during
the year
ended October
31,
2023 as
indicated
in
the
table
below.
Including
this
amount,
expenses
previously
waived/paid
by
Price
Associates
in
the
amount
of $242,000 remain
subject
to
repayment
by
the
fund
at
October
31,
2023.
Any
repayment
of
expenses
previously
waived/paid
by
Price
Associates
during
the
period
would
be
included
in
the
net
investment
income
and
expense
ratios
presented
on
the
accompanying
Financial
Highlights.
In
addition,
the
fund
has
entered
into
service
agreements
with
Price
Associates
and
a
wholly
owned
subsidiary
of
Price
Associates,
each
an
affiliate
of
the
fund
(collectively,
Price).
Price
Associates
provides
certain
accounting
and
administrative
services
to
the
fund.
T.
Rowe
Price
Services,
Inc.
provides
shareholder
and
administrative
services
in
its
capacity
as
the
fund’s
transfer
and
dividend-
disbursing
agent.
For
the
year
ended
October
31,
2023,
expenses
incurred
pursuant
to
these
service
agreements
were
$112,000
for
Price
Associates
and
$2,000
for
T.
Rowe
Price
Services,
Inc.
All
amounts
due
to
and
due
from
Price,
exclusive
of
investment
management
fees
payable,
are
presented
net
on
the
accompanying
Statement
of
Assets
and
Liabilities.
T.
Rowe
Price
Investment
Services,
Inc.
(Investment
Services)
serves
as
distributor
to
the
fund.
Pursuant
to
an
underwriting
agreement,
no
compensation
for
any
distribution
services
provided
is
paid
to
Investment
Services
by
the
fund
(except
for
12b-1
fees
under
a
Board-
approved
Rule
12b-1
plan).
The fund
may
invest
its
cash
reserves
in
certain
open-end
management
investment
companies
managed
by
Price
Associates
and
considered
affiliates
of
the
fund:
the
T.
Rowe
Price
Government
Reserve
Fund
or
the
T.
Rowe
Price
Treasury
Reserve
Fund,
organized
as
money
market
funds
(together,
the
Price
Reserve
Funds).
The
Price
Reserve
Funds
are
offered
as
short-term
investment
options
to
mutual
funds,
trusts,
and
other
accounts
managed
by
Price
Associates
or
its
affiliates
and
are
not
available
for
direct
purchase
by
members
of
the
public.
Cash
collateral
from
securities
lending,
if
any,
is
invested
in
the
T.
Rowe
Price
Government
Reserve Fund. The
Price
Reserve
Funds
pay
no
investment
management
fees.
The
fund may
participate
in
securities
purchase
and
sale
transactions
with
other
funds
or
accounts
advised
by
Price
Associates
(cross
trades),
in
accordance
with
procedures
adopted
by the
fund’s
Board
and
Securities
and
Exchange
Commission
rules,
which
require,
among
other
things,
that
such
purchase
and
sale
cross
trades
be
effected
at
the
independent
current
market
price
of
the
security.
Expense
limitation
0.75%
Expense
limitation
date
02/28/25
(Waived)/repaid
during
the
period
($000s)
$(129)
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
20
During
the
year
ended
October
31,
2023,
the
fund
had
no
purchases
or
sales
cross
trades
with
other
funds
or
accounts
advised
by
Price
Associates.
NOTE
7
-
OTHER
MATTERS
Unpredictable
events
such
as
environmental
or
natural
disasters,
war
and
conflict,
terrorism,
geopolitical
events,
and
public
health
epidemics and
similar
public
health
threats
may
significantly
affect
the
economy
and
the
markets
and
issuers
in
which
the fund
invests.
Certain
events
may
cause
instability
across
global
markets,
including
reduced
liquidity
and
disruptions
in
trading
markets,
while
some
events
may
affect
certain
geographic
regions,
countries,
sectors,
and
industries
more
significantly
than
others,
and
exacerbate
other
pre-
existing
political,
social,
and
economic
risks.
The
global
outbreak
of
COVID-19
and
the
related
governmental
and
public
responses
have
led
and
may
continue
to
lead
to
increased
market
volatility
and
the
potential
for
illiquidity
in
certain
classes
of
securities
and
sectors
of
the
market
either
in
specific
countries
or
worldwide.
In
February
2022,
Russian
forces
entered
Ukraine
and
commenced
an
armed
conflict,
leading
to
economic
sanctions imposed
on
Russia
that
target certain
of
its
citizens
and
issuers
and
sectors
of
the
Russian
economy,
creating
impacts
on
Russian-related
stocks
and
debt
and
greater
volatility
in
global
markets.
In
March
2023,
the
banking
industry
experienced
heightened
volatility,
which
sparked
concerns
of
potential
broader
adverse
market
conditions.
The
extent
of
impact
of
these
events
on
the
US
and
global
markets
is
highly
uncertain.
These
are
recent
examples
of
global
events
which
may
have
a
negative
impact
on
the
values
of
certain
portfolio
holdings
or
the
fund’s
overall
performance.
Management
is
actively
monitoring
the
risks
and
financial
impacts
arising
from
these
events.
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
21
Report
of
Independent
Registered
Public
Accounting
Firm
To
the
Board
of
Directors
of
T.
Rowe
Price
Global
Funds,
Inc.
and
Shareholders
of
T.
Rowe
Price
Institutional
International
Disciplined
Equity
Fund
Opinion
on
the
Financial
Statements
We
have
audited
the
accompanying
statement
of
assets
and
liabilities,
including
the
portfolio
of
investments,
of
T.
Rowe
Price
Institutional
International
Disciplined
Equity
Fund
(one
of
the
funds
constituting
T.
Rowe
Price
Global
Funds,
Inc.,
referred
to
hereafter
as
the
"Fund")
as
of
October
31,
2023,
the
related
statement
of
operations
for
the
year
ended
October
31,
2023,
the
statement
of
changes
in
net
assets
for
each
of
the
two
years
in
the
period
ended
October
31,
2023,
including
the
related
notes,
and
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
October
31,
2023
(collectively
referred
to
as
the
“financial
statements”).
In
our
opinion,
the
financial
statements
present
fairly,
in
all
material
respects,
the
financial
position
of
the
Fund
as
of
October
31,
2023,
the
results
of
its
operations
for
the
year
then
ended,
the
changes
in
its
net
assets
for
each
of
the
two
years
in
the
period
ended
October
31,
2023
and
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
October
31,
2023
in
conformity
with
accounting
principles
generally
accepted
in
the
United
States
of
America.
Basis
for
Opinion
These
financial
statements
are
the
responsibility
of
the
Fund’s
management.
Our
responsibility
is
to
express
an
opinion
on
the
Fund’s
financial
statements
based
on
our
audits.
We
are
a
public
accounting
firm
registered
with
the
Public
Company
Accounting
Oversight
Board
(United
States)
(PCAOB)
and
are
required
to
be
independent
with
respect
to
the
Fund
in
accordance
with
the
U.S.
federal
securities
laws
and
the
applicable
rules
and
regulations
of
the
Securities
and
Exchange
Commission
and
the
PCAOB.
We
conducted
our
audits
of
these
financial
statements
in
accordance
with
the
standards
of
the
PCAOB.
Those
standards
require
that
we
plan
and
perform
the
audit
to
obtain
reasonable
assurance
about
whether
the
financial
statements
are
free
of
material
misstatement,
whether
due
to
error
or
fraud.
Our
audits
included
performing
procedures
to
assess
the
risks
of
material
misstatement
of
the
financial
statements,
whether
due
to
error
or
fraud,
and
performing
procedures
that
respond
to
those
risks.
Such
procedures
included
examining,
on
a
test
basis,
evidence
regarding
the
amounts
and
disclosures
in
the
financial
statements.
Our
audits
also
included
evaluating
the
accounting
principles
used
and
significant
estimates
made
by
management,
as
well
as
evaluating
the
overall
presentation
of
the
financial
statements.
Our
procedures
included
confirmation
of
securities
owned
as
of
October
31,
2023
by
correspondence
with
the
custodian,
transfer
agent
and
brokers;
when
replies
were
not
received
from
brokers,
we
performed
other
auditing
procedures.
We
believe
that
our
audits
provide
a
reasonable
basis
for
our
opinion.
/s/
PricewaterhouseCoopers
LLP
Baltimore,
Maryland
December
19,
2023
We
have
served
as
the
auditor
of
one
or
more
investment
companies
in
the
T.
Rowe
Price
group
of
investment
companies
since
1973.
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
22
TAX
INFORMATION
(UNAUDITED)
FOR
THE
TAX
YEAR
ENDED 10/31/23
We
are
providing
this
information
as
required
by
the
Internal
Revenue
Code.
The
amounts
shown
may
differ
from
those
elsewhere
in
this
report
because
of
differences
between
tax
and
financial
reporting
requirements.
For
taxable
non-corporate
shareholders,
$4,669,000 of
the
fund's
income
represents
qualified
dividend
income
subject
to
a
long-term
capital
gains
tax
rate
of
not
greater
than
20%.
The
fund
will
pass
through
foreign
source
income
of
$4,859,000
and
foreign
taxes
paid
of
$446,000.  
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
23
INFORMATION
ON
PROXY
VOTING
POLICIES,
PROCEDURES,
AND
RECORDS
A
description
of
the
policies
and
procedures
used
by
T.
Rowe
Price
funds
to
determine
how
to
vote
proxies
relating
to
portfolio
securities
is
available
in
each
fund’s
Statement
of
Additional
Information.
You
may
request
this
document
by
calling
1-800-225-5132
or
by
accessing
the
SEC’s
website,
sec.gov.
The
description
of
our
proxy
voting
policies
and
procedures
is
also
available
on
our
corporate
website.
To
access
it,
please
visit
the
following
Web
page:
https://www.troweprice.com/corporate/us/en/utility/policies.html
Scroll
down
to
the
section
near
the
bottom
of
the
page
that
says,
“Proxy
Voting
Guidelines.”
Click
on
the
links
in
the
shaded
box.
Each
fund’s
most
recent
annual
proxy
voting
record
is
available
on
our
website
and
through
the
SEC’s
website.
To
access
it
through
T.
Rowe
Price,
visit
the
website
location
shown
above,
and
scroll
down
to
the
section
near
the
bottom
of
the
page
that
says,
“Proxy
Voting
Records.”
Click
on
the
Proxy
Voting
Records
link
in
the
shaded
box.
RESULTS
OF
PROXY
VOTING
A
Special
Meeting
of
Shareholders
was
held
on
July
24,
2023
for
shareholders
of
record
on
April
7,
2023,
to
elect
the
following
director-
nominees
to
serve
on
the
Board
of
all
Price
Funds.
The
newly
elected
Directors
took
office
effective
July
24,
2023.
The
results
of
the
voting
were
as
follows:
Teresa
Bryce
Bazemore,
Bruce
W.
Duncan,
Robert
J.
Gerrard,
Jr.,
Paul
F.
McBride
and
David
Oestreicher
continue
to
serve
as
Directors
on
the
Board
of
all
Price
Funds.
HOW
TO
OBTAIN
QUARTERLY
PORTFOLIO
HOLDINGS
The
fund
files
a
complete
schedule
of
portfolio
holdings
with
the
Securities
and
Exchange
Commission
(SEC)
for
the
first
and
third
quarters
of
each
fiscal
year
as
an
exhibit
to
its
reports
on
Form
N-PORT.
The
fund’s
reports
on
Form
N-PORT
are
available
electronically
on
the
SEC’s
website
(sec.gov).
In
addition,
most
T.
Rowe
Price
funds
disclose
their
first
and
third
fiscal
quarter-end
holdings
on
troweprice.com
.
TAILORED
SHAREHOLDER
REPORTS
FOR
MUTUAL
FUNDS
AND
EXCHANGE
TRADED
FUNDS
In
October
2022,
the
Securities
and
Exchange
Commission
(SEC)
adopted
rule
and
form
amendments
requiring
Mutual
Funds
and
Exchange-Traded
Funds
to
transmit
concise
and
visually
engaging
streamlined
annual
and
semiannual
reports
that
highlight
key
information
to
shareholders.
Other
information,
including
financial
statements,
will
no
longer
appear
in
the
funds’
shareholder
reports
but
will
be
available
online,
delivered
free
of
charge
upon
request,
and
filed
on
a
semiannual
basis
on
Form
N-CSR.
The
rule
and
form
amendments
have
a
compliance
date
of
July
24,
2024.
Votes
For
Votes
Withheld
Melody
Bianchetto
54,016,226
196,144
Mark
J.
Parrell
53,993,698
218,540
Kellye
L.
Walker
54,002,409
210,013
Eric
L.
Veiel
53,709,880
502,305
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
24
LIQUIDITY
RISK
MANAGEMENT
PROGRAM
In accordance
with
Rule
22e-4
(Liquidity
Rule)
under
the
Investment
Company
Act
of
1940,
as
amended,
the
fund
has
established
a
liquidity
risk
management
program
(Liquidity
Program)
reasonably
designed
to
assess
and
manage
the
fund’s
liquidity
risk,
which
generally
represents
the
risk
that
the
fund
would
not
be
able
to
meet
redemption
requests
without
significant
dilution
of
remaining
investors’
interests
in
the
fund.
The
fund’s
Board
of
Directors
(Board)
has
appointed
the
fund’s
investment
adviser,
T.
Rowe
Price
Associates,
Inc.
(Adviser),
as
the
administrator
of
the
Liquidity
Program.
As
administrator,
the
Adviser
is
responsible
for
overseeing
the
day-to-day
operations
of
the
Liquidity
Program
and,
among
other
things,
is
responsible
for
assessing,
managing,
and
reviewing
with
the
Board
at
least
annually
the
liquidity
risk
of
each
T.
Rowe
Price
fund.
The
Adviser
has
delegated
oversight
of
the
Liquidity
Program
to
a
Liquidity
Risk
Committee
(LRC),
which
is
a
cross-
functional
committee
composed
of
personnel
from
multiple
departments
within
the
Adviser.
The
Liquidity
Program’s
principal
objectives
include
supporting
the
T.
Rowe
Price
funds’
compliance
with
limits
on
investments
in
illiquid
assets
and
mitigating
the
risk
that
the
fund
will
be
unable
to
timely
meet
its
redemption
obligations.
The
Liquidity
Program
also
includes
a
number
of
elements
that
support
the
management
and
assessment
of
liquidity
risk,
including
an
annual
assessment
of
factors
that
influence
the
fund’s
liquidity
and
the
periodic
classification
and
reclassification
of
a
fund’s
investments
into
categories
that
reflect
the
LRC’s
assessment
of
their
relative
liquidity
under
current
market
conditions.
Under
the
Liquidity
Program,
every
investment
held
by
the
fund
is
classified
at
least
monthly
into
one
of
four
liquidity
categories
based
on
estimations
of
the
investment’s
ability
to
be
sold
during
designated
time
frames
in
current
market
conditions
without
significantly
changing
the
investment’s
market
value.
As
required
by
the
Liquidity
Rule,
at
a
meeting
held
on
July
24,
2023,
the
Board
was
presented
with
an
annual
assessment
that
was
prepared
by
the
LRC
on
behalf
of
the
Adviser
and
addressed
the
operation
of
the
Liquidity
Program
and
assessed
its
adequacy
and
effectiveness
of
implementation,
including
any
material
changes
to
the
Liquidity
Program
and
the
determination
of
each
fund’s
Highly
Liquid
Investment
Minimum
(HLIM).
The
annual
assessment
included
consideration
of
the
following
factors,
as
applicable:
the
fund’s
investment
strategy
and
liquidity
of
portfolio
investments
during
normal
and
reasonably
foreseeable
stressed
conditions,
including
whether
the
investment
strategy
is
appropriate
for
an
open-end
fund,
the
extent
to
which
the
strategy
involves
a
relatively
concentrated
portfolio
or
large
positions
in
particular
issuers,
and
the
use
of
borrowings
for
investment
purposes
and
derivatives;
short-term
and
long-term
cash
flow
projections
covering
both
normal
and
reasonably
foreseeable
stressed
conditions;
and
holdings
of
cash
and
cash
equivalents,
as
well
as
available
borrowing
arrangements.
For the
fund
and
other
T.
Rowe
Price
funds,
the
annual
assessment
incorporated
a
report
related
to
a
fund’s
holdings,
shareholder
and
portfolio
concentration,
any
borrowings
during
the
period,
cash
flow
projections,
and
other
relevant
data
for
the
period
of
April
1,
2022,
through
March
31,
2023.
The
report
described
the
methodology
for
classifying
a
fund’s
investments
(including
any
derivative
transactions)
into
one
of
four
liquidity
categories,
as
well
as
the
percentage
of
a
fund’s
investments
assigned
to
each
category.
It
also
explained
the
methodology
for
establishing
a
fund’s
HLIM
and
noted
that
the
LRC
reviews
the
HLIM
assigned
to
each
fund
no
less
frequently
than
annually.
During
the
period
covered
by
the
annual
assessment,
the
LRC
has
concluded,
and
reported
to
the
Board,
that
the
Liquidity
Program
continues
to
operate
adequately
and
effectively
and
is
reasonably
designed
to
assess
and
manage
the
fund’s
liquidity
risk.
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
25
ABOUT
THE
FUND'S
DIRECTORS
AND
OFFICERS
Your
fund
is
overseen
by
a
Board
of
Directors
(Board)
that
meets
regularly
to
review
a
wide
variety
of
matters
affecting
or
potentially
affecting
the
fund,
including
performance,
investment
programs,
compliance
matters,
advisory
fees
and
expenses,
service
providers,
and
business
and
regulatory
affairs.
The
Board
elects
the
fund’s
officers,
who
are
listed
in
the
final
table.
The
directors
who
are
also
employees
or
officers
of
T.
Rowe
Price
are
considered
to
be
“interested”
directors
as
defined
in
Section
2(a)(19)
of
the
1940
Act
because
of
their
relationships
with
T.
Rowe
Price
Associates,
Inc. (T.
Rowe
Price),
and
its
affiliates.
The
business
address
of
each
director
and
officer
is
100
East
Pratt
Street,
Baltimore,
Maryland
21202.
The
Statement
of
Additional
Information
includes
additional
information
about
the
fund
directors
and
is
available
without
charge
by
calling
a
T.
Rowe
Price
representative
at
1-800-638-5660.
INDEPENDENT
DIRECTORS
(a)
Name
(Year
of
Birth)
Year
Elected
[Number
of
T.
Rowe
Price
Portfolios
Overseen]
Principal
Occupation(s)
and
Directorships
of
Public
Companies
and
Other
Investment
Companies
During
the
Past
Five
Years
Teresa
Bryce
Bazemore
(1959)
2018
[209]
President
and
Chief
Executive
Officer,
Federal
Home
Loan
Bank
of
San
Francisco
(2021
to
present);
Chief
Executive
Officer,
Bazemore
Consulting
LLC
(2018
to
2021);
Director,
Chimera
Investment
Corporation
(2017
to
2021);
Director,
First
Industrial
Realty
Trust
(2020
to
present);
Director,
Federal
Home
Loan
Bank
of
Pittsburgh
(2017
to
2019)
Melody
Bianchetto
(1966)
2023
[209]
Vice
President
for
Finance,
University
of
Virginia
(2015
to
2023)
Bruce
W.
Duncan
(1951)
2013
[209]
President,
Chief
Executive
Officer,
and
Director,
CyrusOne,
Inc.
(2020
to
2021);
Chair
of
the
Board
(2016
to
2020)
and
President
(2009
to
2016),
First
Industrial
Realty
Trust,
owner
and
operator
of
industrial
properties;
Member,
Investment
Company
Institute
Board
of
Governors
(2017
to
2019);
Member,
Independent
Directors
Council
Governing
Board
(2017
to
2019);
Senior
Advisor,
KKR
(2018
to
2022);
Director,
Boston
Properties
(2016
to
present);
Director,
Marriott
International,
Inc.
(2016
to
2020)
Robert
J.
Gerrard,
Jr.
(1952)
2012
[209]
Chair
of
the
Board,
all
funds
(July
2018
to
present)
Paul
F.
McBride
(1956)
2013
[209]
Advisory
Board
Member,
Vizzia
Technologies
(2015
to
present);
Board
Member,
Dunbar
Armored
(2012
to
2018)
Mark
J.
Parrell
(1966)
2023
[209]
Board
of
Trustees
Member
and
Chief
Executive
Officer
(2019
to
present),
President
(2018
to
present),
Executive
Vice
President
and
Chief
Financial
Officer
(2007
to
2018),
and
Senior
Vice
President
and
Treasurer
(2005
to
2007),
EQR;
Member,
Nareit
Dividends
Through
Diversity,
Equity
&
Inclusion
CEO
Council
and
Chair,
Nareit
2021
Audit
and
Investment
Committee
(2021);
Advisory
Board,
Ross
Business
School
at
University
of
Michigan
(2015
to
2016);
Member,
National
Multifamily
Housing
Council
and
served
as
Chair
of
the
Finance
Committee
(2015
to
2016);
Member,
Economic
Club
of
Chicago;
Director,
Brookdale
Senior
Living,
Inc.
(2015
to
2017);
Director,
Aviv
REIT,
Inc.
(2013
to
2015);
Director,
Real
Estate
Roundtable
and
the
2022
Executive
Board
Nareit;
Board
of
Directors
and
Chair
of
the
Finance
Committee,
Greater
Chicago
Food
Depository
Kellye
L.
Walker
(1966)
2021
[209]
Executive
Vice
President
and
Chief
Legal
Officer,
Eastman
Chemical
Company
(April
2020
to
present);
Executive
Vice
President
and
Chief
Legal
Officer,
Huntington
Ingalls
Industries,
Inc.
(January
2015
to
March
2020);
Director,
Lincoln
Electric
Company
(October
2020
to
present)
(a)
All
information
about
the
independent
directors
was
current
as
of
December
31,
2022,
unless
otherwise
indicated,
except
for
the
number
of
portfolios
overseen,
which
is
current
as
of
the
date
of
this
report.
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
26
INTERESTED  DIRECTORS
(a)
OFFICERS
Name
(Year
of
Birth)
Year
Elected
[Number
of
T.
Rowe
Price
Portfolios
Overseen]
Principal
Occupation(s)
and
Directorships
of
Public
Companies
and
Other
Investment
Companies
During
the
Past
Five
Years
David
Oestreicher
(1967)
2018
[209]
Director,
Vice
President,
and
Secretary,
T.
Rowe
Price,
T.
Rowe
Price
Investment
Services,
Inc.,
T.
Rowe
Price
Retirement
Plan
Services,
Inc.,
and
T.
Rowe
Price
Services,
Inc.;
Director
and
Secretary,
T.
Rowe
Price
Investment
Management,
Inc.
(Price
Investment
Management);
Vice
President
and
Secretary,
T.
Rowe
Price
International
(Price
International);
Vice
President,
T.
Rowe
Price
Hong
Kong
(Price
Hong
Kong),
T.
Rowe
Price
Japan
(Price
Japan),
and
T.
Rowe
Price
Singapore
(Price
Singapore);
General
Counsel,
Vice
President,
and
Secretary,
T.
Rowe
Price
Group,
Inc.;
Chair
of
the
Board,
Chief
Executive
Officer,
President,
and
Secretary,
T.
Rowe
Price
Trust
Company;
Principal
Executive
Officer
and
Executive
Vice
President,
all
funds
Eric
L.
Veiel,
CFA
(1972)
2022
[209]
Director
and
Vice
President,
T.
Rowe
Price;
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company;
Vice
President,
Global
Funds
(a)
All
information
about
the
interested
directors
was
current
as
of
December
31,
2022,
unless
otherwise
indicated,
except
for
the
number
of
portfolios
overseen,
which
is
current
as
of
the
date
of
this
report.
Name
(Year
of
Birth)
Position
Held
With Global
Funds 
Principal
Occupation(s) 
Roy
H.
Adkins
(1970)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Kennard
W.
Allen
(1977)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Peter
I.
Botoucharov
(1965)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Tala
Boulos
(1984)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Armando
(Dino)
Capasso
(1974)
Chief
Compliance
Officer
and
Vice
President
Chief
Compliance
Officer
and
Vice
President,
T.
Rowe
Price
and
Price
Investment
Management;
Vice
President,
T.
Rowe
Price
Group,
Inc.;
formerly,
Chief
Compliance
Officer,
PGIM
Investments
LLC
and
AST
Investment
Services,
Inc.
(ASTIS)
(to
2022);
Chief
Compliance
Officer,
PGIM
Retail
Funds
complex
and
Prudential
Insurance
Funds
(to
2022);
Vice
President
and
Deputy
Chief
Compliance
Officer,
PGIM
Investments
LLC
and
ASTIS
(to
2019)
Carolyn
Hoi
Che
Chu
(1974)
Vice
President
Vice
President,
Price
Hong
Kong
and
T.
Rowe
Price
Group,
Inc.
Maria
Elena
Drew
(1973)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Alan
S.
Dupski,
CPA
(1982)
Principal
Financial
Officer,
Vice
President,
and
Treasurer
Vice
President,
Price
Investment
Management,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Bridget
A.
Ebner
(1970)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Cheryl
Emory
(1963)
Assistant
Secretary 
Assistant
Vice
President
and
Assistant
Secretary,
T.
Rowe
Price;
Assistant
Secretary,
T.
Rowe
Price
Group,
Inc.,
Price
Investment
Management,
Price
International,
Price
Hong
Kong,
Price
Singapore,
T.
Rowe
Price
Investment
Services,
Inc.,
T.
Rowe
Price
Retirement
Plan
Services,
Inc.,
and
T.
Rowe
Price
Trust
Company
Aaron
Gifford,
CFA
(1987)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Richard
L.
Hall
(1979)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
27
Name
(Year
of
Birth)
Position
Held
With Global
Funds 
Principal
Occupation(s) 
Cheryl
Hampton,
CPA
(1969)
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company;
formerly,
Tax
Director,
Invesco
Ltd.
(to
2021);
Vice
President,
Oppenheimer
Funds,
Inc.
(to
2019)
Arif
Husain,
CFA
(1972)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Andrew
J.
Keirle
(1974)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Benjamin
Kersse,
CPA
(1989)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Trust
Company
Paul
J.
Krug,
CPA
(1964)
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Christopher
J.
Kushlis,
CFA
(1976)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Anh Lu
(1968)
Vice
President
Vice
President,
Price
Hong
Kong,
Price
International, and
T.
Rowe
Price
Group,
Inc.
Sebastien
Mallet
(1974)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Eric
C.
Moffett
(1974)
Executive
Vice
President
Vice
President,
Price
Singapore
and
T.
Rowe
Price
Group,
Inc.
Samy
B.
Muaddi,
CFA
(1984)
Executive
Vice
President
Vice
President,
T.
Rowe
Price,
Price
International,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Tobias
F. Mueller,
CFA
(1980)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Kenneth
A. Orchard
(1975)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Oluwaseun Oyegunle,
CFA
(1984)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Fran
M.
Pollack-Matz
(1961)
Vice
President
and
Secretary 
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
T.
Rowe
Price
Investment
Services,
Inc., T.
Rowe
Price
Services,
Inc.,
and
T.
Rowe
Price
Trust
Company
Federico
Santilli,
CFA
(1974)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Richard
Sennett,
CPA
(1970)
Assistant
Treasurer
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Gabriel
Solomon
(1977)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Verena
E.
Wachnitz,
CFA
(1978)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Megan
Warren
(1968)
Vice
President
OFAC
Sanctions
Compliance
Officer
and
Vice
President,
Price
Investment
Management;
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
T.
Rowe
Price
Retirement
Plan
Services,
Inc.,
T.
Rowe
Price
Services,
Inc.,
and
T.
Rowe
Price
Trust
Company
Marta
Yago
(1977)
Vice
President
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Ernest
C.
Yeung,
CFA
(1979)
Vice
President
Director
and
Vice
President,
Price
Hong
Kong;
Vice
President,
T.
Rowe
Price
Group,
Inc.
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
OFFICERS
(CONTINUED)
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
28
Name
(Year
of
Birth)
Position
Held
With Global
Funds 
Principal
Occupation(s) 
Ellen
York
(1988)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
OFFICERS
(CONTINUED)
100
East
Pratt
Street
Baltimore,
MD
21202
T.
Rowe
Price
Investment
Services,
Inc.
Call
1-800-225-5132
to
request
a
prospectus
or
summary
prospectus;
each
includes
investment
objectives,
risks,
fees,
expenses,
and
other
information
that
you
should
read
and
consider
carefully
before
investing.
202312-3146036
E177-050
12/23


Item 1. (b) Notice pursuant to Rule 30e-3.

Not applicable.

Item 2. Code of Ethics.

The registrant has adopted a code of ethics, as defined in Item 2 of Form N-CSR, applicable to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of this code of ethics is filed as an exhibit to this Form N-CSR. No substantive amendments were approved or waivers were granted to this code of ethics during the period covered by this report.

Item 3. Audit Committee Financial Expert.

The registrant’s Board of Directors has determined that Ms. Teresa Bryce Bazemore qualifies as an audit committee financial expert, as defined in Item 3 of Form N-CSR. Ms. Bazemore is considered independent for purposes of Item 3 of Form N-CSR.

Item 4. Principal Accountant Fees and Services.

(a) – (d)    Aggregate fees billed for the last two fiscal years for professional services rendered to, or on behalf of, the registrant by the registrant’s principal accountant were as follows:

 

          

      

2023

           

2022

 
  Audit Fees    $ 25,925                        $ 24,349  
  Audit-Related Fees      -           -  
  Tax Fees      -           -  
  All Other Fees      -           -  

Audit fees include amounts related to the audit of the registrant’s annual financial statements and services normally provided by the accountant in connection with statutory and regulatory filings. Audit-related fees include amounts reasonably related to the performance of the audit of the registrant’s financial statements and specifically include the issuance of a report on internal controls and, if applicable, agreed-upon procedures related to fund acquisitions. Tax fees include amounts related to services for tax compliance, tax planning, and tax advice. The nature of these services specifically includes the review of distribution calculations and the preparation of Federal, state, and excise tax returns. All other fees include the registrant’s pro-rata share of amounts for agreed-upon procedures in conjunction with service contract approvals by the registrant’s Board of Directors/Trustees.

 

(e)(1) The registrant’s audit committee has adopted a policy whereby audit and non-audit services performed by the registrant’s principal accountant for the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant require pre-approval in advance at regularly scheduled audit committee meetings. If such a service is required between regularly scheduled audit committee meetings, pre-approval may be authorized by one audit committee member with ratification at the next scheduled audit committee meeting. Waiver of pre-approval for audit or non-audit services requiring fees of a de minimis amount is not permitted.

(2) No services included in (b) – (d) above were approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.

 


(f) Less than 50 percent of the hours expended on the principal accountant’s engagement to audit the registrant’s financial statements for the most recent fiscal year were attributed to work performed by persons other than the principal accountant’s full-time, permanent employees.

(g) The aggregate fees billed for the most recent fiscal year and the preceding fiscal year by the registrant’s principal accountant for non-audit services rendered to the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant were $1,584,000 and $2,760,000, respectively.

(h) All non-audit services rendered in (g) above were pre-approved by the registrant’s audit committee. Accordingly, these services were considered by the registrant’s audit committee in maintaining the principal accountant’s independence.

Item 5. Audit Committee of Listed Registrants.

Not applicable.

Item 6. Investments.

(a) Not applicable. The complete schedule of investments is included in Item 1 of this Form N-CSR.

(b) Not applicable.

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable.

Item 8. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable.

Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable.

Item 10. Submission of Matters to a Vote of Security Holders.

There has been no change to the procedures by which shareholders may recommend nominees to the registrant’s board of directors.

Item 11. Controls and Procedures.

(a) The registrant’s principal executive officer and principal financial officer have evaluated the registrant’s disclosure controls and procedures within 90 days of this filing and have concluded that the registrant’s disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-CSR was recorded, processed, summarized, and reported timely.

(b) The registrant’s principal executive officer and principal financial officer are aware of no change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 


Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable.

Item 13. Exhibits.

 

(a)(1)    

The registrant’s code of ethics pursuant to Item 2 of Form N-CSR is attached.

(2)    

Separate certifications by the registrant’s principal executive officer and principal financial officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(a) under the Investment Company Act of 1940, are attached.

(3)    

Written solicitation to repurchase securities issued by closed-end companies: not applicable.

(b)        

A certification by the registrant’s principal executive officer and principal financial officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(b) under the Investment Company Act of 1940, is attached.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

T. Rowe Price Global Funds, Inc.
By  

/s/ David Oestreicher

            
  David Oestreicher  
  Principal Executive Officer  
Date       December 19, 2023  

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By  

/s/ David Oestreicher

            
  David Oestreicher  
  Principal Executive Officer  
Date   December 19, 2023  
By  

/s/ Alan S. Dupski

 
  Alan S. Dupski  
  Principal Financial Officer  
Date       December 19, 2023  
 
EX-99.CERT 2 d610564dex99cert.htm 302 CERTIFICATIONS 302 CERTIFICATIONS

Item 13. (a)(2)

CERTIFICATIONS

I, David Oestreicher, certify that:

 

1.

I have reviewed this report on Form N-CSR of T. Rowe Price Institutional International Disciplined Equity Fund;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

 

  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: December 19, 2023     

/s/ David Oestreicher

     David Oestreicher
     Principal Executive Officer


CERTIFICATIONS

I, Alan S. Dupski, certify that:

 

1.

I have reviewed this report on Form N-CSR of T. Rowe Price Institutional International Disciplined Equity Fund;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

 

  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: December 19, 2023

     

/s/ Alan S. Dupski

     

Alan S. Dupski

     

Principal Financial Officer

EX-99.906CE 3 d610564dex99906ce.htm 906 CERTIFICATIONS 906 CERTIFICATIONS

Item 13. (b)

CERTIFICATION UNDER SECTION 906 OF SARBANES-OXLEY ACT OF 2002

Name of Issuer: T. Rowe Price Institutional International Disciplined Equity Fund

In connection with the Report on Form N-CSR for the above named Issuer, the undersigned hereby certifies, to the best of his knowledge, that:

 

  1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;

 

  2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

 

Date: December 19, 2023      

/s/ David Oestreicher

      David Oestreicher
      Principal Executive Officer
Date: December 19, 2023      

/s/ Alan S. Dupski

      Alan S. Dupski
      Principal Financial Officer
EX-99.CODE ETH 4 d610564dex99codeeth.htm CODE OF ETHICS CODE OF ETHICS

CODE OF ETHICS FOR PRINCIPAL EXECUTIVE AND SENIOR FINANCIAL

OFFICERS OF THE T. ROWE PRICE MUTUAL FUNDS AND EXCHANGE-

TRADED FUNDS

UNDER THE SARBANES-OXLEY ACT OF 2002

I.  General Statement. This Code of Ethics for the T. Rowe Price Mutual Funds and Exchange-Traded Funds (the “Price ETFs” and, together with the Mutual Funds, the “Price Funds”) has been designed to bring the Price Funds into compliance with the applicable requirements of the Sarbanes-Oxley Act of 2002 (the “Act”) and rules promulgated by the Securities and Exchange Commission thereunder (“Regulations”). This Price Funds’ Code of Ethics (the “S-O Code”) applies solely to the Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer or Controller of, or persons performing similar functions for, a Price Fund (whether such persons are employed by a Price Fund or third party) (“Covered Officers”). The “Price Funds” shall include each mutual fund and ETF that is managed, sponsored and distributed by affiliates of T. Rowe Price Group, Inc. (“Group”). The investment managers to the Price Funds will be referred to as the “Price Fund Advisers.” A list of Covered Officers is attached as Exhibit A.

The Price Fund Advisers have, along with their parent, T. Rowe Price Group, Inc. (“Group”) also maintained a comprehensive Code of Ethics and Conduct (the “Group Code”) since 1972, which applies to all officers, directors and employees of the Price Funds, Group and its affiliates.

As mandated by the Act, Group has adopted a Code (the “Group S-O Code”), similar to the Price Funds S-O Code, which applies solely to its principal executive and senior financial officers. The Group S-O Code and the Price Funds S-O Code will be referred to collectively as the “S-O Codes”.

The Price Funds S-O Code has been adopted by the Price Funds in accordance with the Act and Regulations thereunder and will be administered in conformity with the disclosure requirements of Item 2 of Form N-CSR. The S-O Codes are attachments to the Group Code. In many respects the S-O Codes are supplementary to the Group Code, but the Group Code is administered separately from the S-O Codes, as the S-O Codes are from each other.

II.  Purpose of the Price Funds S-O Code. The purpose of the Price Funds S-O Code, as mandated by the Act and the Regulations, is to establish standards that are reasonably designed to deter wrongdoing and to promote:

Ethical Conduct. Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships.

Disclosure. Full, fair, accurate, timely and understandable disclosure in reports and documents that the Price Funds file with, or submit to, the SEC and in other public communications made by the Price Funds.

Compliance. Compliance with applicable governmental laws, rules and regulations.

Reporting of Violations. The prompt internal reporting of violations of the Price Funds S-O Code to an appropriate person or persons identified in the Price Funds S-O Code.

Accountability. Accountability for adherence to the Price Funds S-O Code.

 

1


III.  Covered Officers Should Handle Ethically Actual and Apparent Conflicts of Interest.

Overview. Each Covered Officer owes a duty to the Price Funds to adhere to a high standard of honesty and business ethics and should be sensitive to situations that may give rise to actual as well as apparent conflicts of interest.

A “conflict of interest” occurs when a Covered Officer’s private interest interferes with the interests of, or his or her service to, the Price Funds. For example, a conflict of interest would arise if a Covered Officer, or a member of his or her family, receives improper personal benefits as a result of his or her position with a Price Fund.

Certain conflicts of interest covered by the Price Funds S-O Code arise out of the relationships between Covered Officers and the Price Funds and may already be subject to provisions regulating conflicts of interest in the Investment Company Act of 1940 (“Investment Company Act”), the Investment Advisers Act of 1940 (“Investment Advisers Act”) and the Group Code. For example, Covered Officers may not individually engage in certain transactions (such as the purchase or sale of securities or other property) with a Price Fund because of their status as “affiliated persons” of a Price Fund. The compliance programs and procedures of the Price Funds and Price Fund Advisers are designed to prevent, or identify and correct, violations of these provisions.

Although typically not presenting an opportunity for improper personal benefit, conflicts arise from, or as a result of, the contractual relationship between a Price Fund and its Price Fund Adviser (and its affiliates) of which the Covered Officers may also be officers or employees. As a result, the Price Funds S-O Code recognizes that the Covered Officers will, in the normal course of their duties (whether formally for the Price Funds or for the Price Fund Advisers, or for both), be involved in establishing policies and implementing decisions which will have different effects on these entities. The participation of the Covered Officers in such activities is inherent in the contractual relationship between each Price Fund and its respective Price Fund Adviser. Such participation is also consistent with the performance by the Covered Officers of their duties as officers of the Price Funds and, if consistent with the provisions of the Investment Company Act and the Investment Advisers Act, it will be deemed to have been handled ethically.

Other conflicts of interest are covered by the Price Funds and Price ETFs S-O Code, even if these conflicts of interest are not addressed by or subject to provisions in the Investment Company Act and the Investment Advisers Act.

Whenever a Covered Officer is confronted with a conflict of interest situation where he or she is uncertain as to the appropriate action to be taken, he or she should discuss the matter with the Chairperson of Group’s Ethics Committee or another member of the Committee.

Handling of Specific Types of Conflicts. Each Covered Officer (and close family members) must not:

Entertainment. Accept entertainment from any company with which any Price Fund or any Price Fund Adviser has current or prospective business dealings including portfolio companies, unless such entertainment is in full compliance with the policy on entertainment as set forth in the Group Code.

 

2


Gifts. Accept any gifts, except as permitted by the Group Code.

Improper Personal Influence. Use his or her personal influence or personal relationships improperly to influence investment decisions, brokerage allocations or financial reporting by the Price Funds to the detriment of any one or more of the Price Funds.

Taking Action at the Expense of a Price Fund. Cause a Price Fund to take action, or fail to take action, for the personal benefit of the Covered Officer rather than for the benefit of one or more of the Price Funds.

Misuse of Price Funds’ Transaction Information. Use knowledge of portfolio transactions made or contemplated for a Price Fund or any other clients of the Price Fund Advisers to trade personally or cause others to trade in order to take advantage of or avoid the market impact of such portfolio transactions; and in connection with Price ETFs that do not disclose portfolio holdings daily, use knowledge of pending changes to an ETF’s proxy portfolio holdings for such purposes.

Outside Business Activities. Engage in any outside business activity that detracts from a Covered Officer’s ability to devote appropriate time and attention to his or her responsibilities to a Price Fund.

Service Providers. Excluding Group and its affiliates, have any ownership interest in, or any consulting or employment relationship with, any of the Price Funds’ service providers, except that an ownership interest in public companies is permitted

Receipt of Payments. Have a direct or indirect financial interest in commissions, transaction charges, spreads or other payments paid by a Price Fund for effecting portfolio transactions or for selling or redeeming shares other than an interest (such as compensation or equity ownership) arising from the Covered Officer’s employment by Group or any of its affiliates.

Service as a Director or Trustee. Serve as a director, trustee or officer of any public or private company or a non-profit organization that issues securities eligible for purchase by any of the Price Funds, unless approval is obtained as required by the Group Code.

IV.  Covered Officers’ Specific Obligations and Accountabilities.

A.  Disclosure Requirements and Controls. Each Covered Officer must familiarize himself or herself with the disclosure requirements (Form N-lA registration statement, proxy (Schedule 14A), shareholder reports, Forms N-CEN, N-CSR, etc.) applicable to the Price Funds and the disclosure controls and procedures of the Price Fund and the Price Fund Advisers.

B.  Compliance with Applicable Law. It is the responsibility of each Covered Officer to promote compliance with all laws, rules and regulations applicable to the Price Funds and the Price Fund Advisers. Each Covered Officer should, to the extent appropriate within his or her area of responsibility, consult with other officers and employees of the Price Funds and the Price Fund Advisers and take other appropriate steps with the goal of promoting full, fair, accurate, timely and understandable disclosure in the reports and documents the Price Funds file with, or submit to, the SEC, and in other public

 

3


communications made by the Price Funds.

C.   Fair Disclosure. Each Covered Officer must not knowingly misrepresent, or cause others to misrepresent, facts about a Price Fund to others, whether within or outside the Price organization, including to the Price Fund’s directors and auditors, and to governmental regulators and self-regulatory organizations.

D.  Initial and Annual Affirmations. Each Covered Officer must:

1.  Upon adoption of the Price Funds S-O Code (or thereafter, as applicable, upon becoming a Covered Officer), affirm in writing that he or she has received, read, and understands the Price Funds S-O Code.

2.  Annually affirm that he or she has complied with the requirements of the Price Funds S-O Code.

E.  Reporting of Material Violations of the Price Funds S-O Code. If a Covered Officer becomes aware of any material violation of the Price Funds S-O Code or laws and governmental rules and regulations applicable to the operations of the Price Funds, he or she must promptly report the violation (“Report”) to the Chief Compliance Officer of the Price Funds (“CCO”). Failure to report a material violation will be considered itself a violation of the Price Funds S-O Code. The CCO is identified in the attached Exhibit B.

It is the Price Funds’ policy that no retaliation or other adverse action will be taken against any Covered Officer or other employee of a Price Fund, a Price Fund Adviser or their affiliates based upon any lawful actions of the Covered Officer or employee with respect to a Report made in good faith.

F.  Annual Disclosures. Each Covered Officer must report, at least annually, all affiliations or other relationships as called for in the “Annual Compliance Certification” for T. Rowe Price Group.

V.  Administration of the Price Funds S-O Code. The Ethics Committee is responsible for administering the Price Funds S-O Code and applying its provisions to specific situations in which questions are presented.

A.  Waivers and Interpretations. The Chairperson of the Ethics Committee has the authority to interpret the Price Funds S-O Code in any particular situation and to grant waivers where justified, subject to the approval of the Joint Audit Committee of the Price Funds. All material interpretations concerning Covered Officers will be reported to the Joint Audit Committee of the Price Funds at its next meeting. Waivers, including implicit waivers, to Covered Officers will be publicly disclosed as required in the Instructions to N-CSR. Pursuant to the definition in the Regulations, an implicit waiver means a Price Fund’s failure to take action within a reasonable period of time regarding a material departure from a provision of the Price Funds S-O Code that has been made known to an “executive officer” (as defined in Rule 3b-7 under the Securities Exchange Act of 1934) of a Price Fund. An executive officer of a Price Fund includes its president and any vice-president in charge of a principal business unit, division or function.

B.  Violations/Investigations. The following procedures will be followed in

 

4


investigating and enforcing the Price Funds S-O Code:

1.  The CCO will take or cause to be taken appropriate action to investigate any potential or actual violation reported to him or her.

2.  The CCO, after consultation if deemed appropriate with Outside Counsel to the Price Funds, will make a recommendation to the appropriate Price Funds Board regarding the action to be taken with regard to each material violation. Such action could include any of the following: a letter of censure or suspension, a fine, a suspension of trading privileges or termination of officership or employment. In addition, the violator may be required to surrender any profit realized (or loss avoided) from any activity that is in violation of the Price Funds S-O Code.

3.  Investigations of Whistleblower complaints related to Price Funds will be handled in accordance with the T. Rowe Price Global Whistleblower Policy.

VI.  Amendments to the Price Funds S-O Code. Except as to the contents of Exhibit A and Exhibit B, the Price Funds S-O Code may not be materially amended except in written form, which is specifically approved or ratified by a majority vote of each Price Fund Board, including a majority of the independent directors on each Board.

VII.  Confidentiality. All reports and records prepared or maintained pursuant to the Price Funds S-O Code will be considered confidential and shall be maintained and protected accordingly. Except as otherwise required by law, the Price Funds S-O Code or as necessary in connection with regulations under the Price Funds S-O Code, such matters shall not be disclosed to anyone other than the directors of the appropriate Price Fund Board, Outside Counsel to the Price Funds, members of the Ethics Committee and the CCO and authorized persons on his or her staff.

Adoption Date:    10/22/03

Last Revised:       05/11/2022 (Exhibit B revised)

 

5


Exhibit A

Persons Covered by the Price Funds and

Price ETFs S-O Code of Ethics

David Oestreicher, Executive Vice President and Principal Executive Officer

Alan S. Dupski, Treasurer and Principal Financial Officer

Exhibit B

Dino Capasso, Chief Compliance Officer

 

6